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ABSTRACT 
Acid secretion is mediated by hormonal, paracrine, neurocrine and 
luminal factors. The major acid secretagogues are gastrin, 
histamine and acetylcholine. Controversy exists regarding the 
specific actions and interactions of these agents upon the acid 
secreting parietal cell. Code (1956, 1977) suggested that histamine 
is the final common pathway for all acid secretagogues. However 
Soll, using oxygen consumption (1978 a, b) and (
14c)- aminopyrine 
uptake by isolated canine parietal cells (1980) as an index of 
acid secretion, showed independent and potentiating effects of these 
agents. Gastrin was only a weak stimulus for oxygen uptake and did so 
only in high doses and in the presence of the phosphodiesterase 
inhibitor isobutyl-methylxanthine. In contrast, Loveridge et al 
(1974) described a quantitative cytochemical assay, which detects 
changes in parietal cell carbonic anhydrase (CA) and is sensitive to 
15 -12 gastrin in concentrations of 2.5 x 10- to 2.5 x 10 mol/1. 
CA is present in the stomach of all acid secreting species. Its 
function appears to be the maintenance of intracellular acid-base 
balance and is necessary for stimulated, but not basal acid 
secretion. Parietal cell CA activity may therefore be regarded as 
an index of parietal cell function. 
Since Loveridge et al (1974) had shown activation of CA by 
concentrations of gastrin lower than that found in the serum from 
fasting individuals and as CA activity is an index of parietal 
cell function, Loveridge's model was adapted and utilised to study 




CA activity was measured in 18 µm sections obtained from fundic 
mucosa of fasted guinea pigs. CA catalysed the formation of OH 
ions which were trapped with cobaltand · precipitated with hydrogen sulphide 
to form a cobalt sulphide precipitate in the cytoplasm of the 
parietal cells. The density of the staining, which was measured in 
15 - 20 cells per section by quantitative cytochemistry with a 
Vickers M85 scanning microdensitometer, was a reflection of CA 
activity. The coefficient of variation in staining between the 
cells of one section was 2.2 - . 6.9%. 
Heptadecapeptide gastrin (G17~I) (2.J x .16~ 15 to 2.5 x 1o- 12mol/l), 
histamine (5.8 x 10- 17 to 1.0 x 1o- 14mol/l) and carbamylcholine 
-12 9 (1.2 x 10 to 1.0 x 10- mol/1) caused dose-related increases in 
CA activity. The optimal response time for all three agents was 90 
seconds. The response to G17-I was inhibited by boiling the tissue, 
by acetazolamide (1o-5M) and by anoxia. After an anoxic period 
there was incomplete recovery of the G17-I response. 
Comparing the 0
50
,s (dose causing half-maximal effects), histamine 
was the most potent of the secretagogues, being 100 times more 
potent than gastrin which was in turn 400 times more potent than 
carbamylcholine. The maximum effect of gastrin, however was 
approximately 50% higher than either histamine or carbamylcholine. 
-16 The addition of subthreshold doses of G17-I (2.5 x 10 M) to each 
concentration of histamine and vice versa, of subthreshold doses 
of histamine (1.0 x 10-l7M) to each concentration of G17-I 
significantly reduced the minimum effective dose and the 0 50 
calculated from the regression lines for histamine and G17-I 
respectively. Subthreshold doses of neither agent altered the 
carbamylcholine dose response curves. 
Moreover, the addition of a subthreshold dose of carbamylcholine 
-14 (1.0 x 10 M) did not al~er the histamine dose response curve 
but did cause a small reduction in the maximal effect of gastrin. 
. . -14 + 
8~ Histamine (1.0 x 10 M)-stimulated CA activity was reduced 74- 7- ~ 
by the addition of the histamine H
2
-receptor blocking agent, 
-12 + ~ cimetidine, whereas G17-I (2.5 x 10 M) was reduced by 23- 4,o. 
Cimetidine did not significantly alter carbamylcholine-stimulated 
CA activity. Atropine (10-5M) in contrast had no significant effect 
upon either histamine-or gastrin-stimulated CA activity but inhibited 
carbamylcholine (1.0 x 10-9 mol/1)-stimulated activity by 79: 9%. 
These studies indicate firstly that CA in guinea pig parietal tissue 
is activated by G17-I, histamine and carbamylcholine independently 
and secondly, that G17-I and histamine potentiate each other and 
act independently of cholinergic pathways. 
Lastly to show the independence of action of the secretagogues the 
effect of the calcium channel blocking agent lanthanum chloride 
( 10-
6
M) on gastrin-,histamine-and carbamylcholine-stimulated CA 
activity was tested. Lanthanum caused 77! 8% inhibition of the 
carbamylcholine (1.0 x lo-9 mol/1) effect, 45 ! 10% inhibition of 
-12 
the gastrin (2.5 x 10 mol/1) effect and 2 ~ 9% inhibition of the 
histamine (1.0 x 1o-
14
mol/l) effect. This is further evidence in 
favour of the independent mechanisms of action of the acid secreta-
gogues. 
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Gastrin comprises a group of circulating peptides of varying molecular 
forms, including big gastrin (GJ4), little gastrin (G17) and mini-
gastrin (G14) , . all of which may be sulphated or non-sulphated. 
Cholecystokinin (CCK) shares a common carboxyterminal pentapeptide 
sequence and the smaller molecular weight forms may also have an 
effect in acid secretion. The potency of these peptides in acid 
secretion is difficult to assess because of varying rates of 
endogenous secretion and degradation. This could be overcome by 
measurement of potency at a cellular level by quantitating their 
effect upon CA activity. Synthetic human G17-I (SHG-17-1), natural 
human G17-I (NHG-17-I), NHG-17-II, and the carboxyterminal deca-
peptide had similar effects on CA activity. Pentagastrin and CCK-
octapeptide caused dose-dependent increases in CA activity parallel 
to SHG-17-I with relative potencies of J2% and 4% respectively. 
GJ4-I caused a non-parallel dose-dependent increase in CA activity 
with a similar potency to SHG-17-I. The amino-terminal decapeptide 
of G17-I had no effect on CA activity and confirmed that the 
biological activity of gastrin lies at the carboxyterminal. 
The last section of this thesis deals with the measurement of the 
carbonic anhydrase stimulating activity (CASA) of serum in comparison 
with the gastrin radio-immunoassay. Loveridge et al (1974) described 
this assay as a cytochemical bioassay for gastrin but since other 
secretagogues stimulate CA activity this may not be specific for 
gastrin. However, removal of gastrin from serum oy charcoal 
absorption and affinity chromatography removed all CASA from the 
serum, suggesting that gastrin may in fact be the major circulating 
CASA.However, since no specific precautions were taken to prevent 
degradation of histamine, which occurs very rapidly in serum, one 
cannot be certain of this. 
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There was no correlation between the immunoreactive gastrins 
measured by two antisera and the CASA in either the fasting or 
post-prandial serum samples. Following a meal theCASA rose more 
slowly than the immunoreactive gastrins and reached a peak at 60 
minutes (compared to 15 minutes for the immunoreactive gastrins) 
and fell more rapidly to reach baseline by 120 minutes (compared to 
180 minutes for the immunoreactive gastrins). It is possible that 
the effects of CASA in serum may be modulated by circulating 
inhibitors and other secretagogues whereas the immunoreactive 
gastrins include a number with varying biological activity. This may 
account for the disparities noted. Patients with hypergastrinaemia 
had a significantly elevated level of CASA in their serum although 
again, the correlation between CASA and immunoreactive gastrins was 
poor. 
This thesis thus presents work designed to study the effects of 
acid secretagogues upon the parietal cell, in order to gain a 
greater understanding of their modes of action, and interaction 
and the role of circulating secretagogues in the mediation of 
parietal cell function, with the aim of increasing the understanding 
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J'- 5'cyclic adenosine monophosphate 
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OBJECTIVES OF THE STUDY 
One may embark upon a project aimed at answering a specific 
question, during the course of which other questions are unearthed, 
tackled and solved, but the original question is never truly 
answered. The work to be described in this thesis proceeded in much 
this manner. Prof. Aaron Vinik, who was Co-director of the Endocrine 
and Diabetes research group at the University of Cape Town, had for 
several years been interested in the characterisation and measure-
ments of the various species forms of gastrin-like molecules present 
in tissue and serum. The physiological role of these gastrins in 
acid secretion and their possible pathophysiological role in peptic 
ulcer disease was, and still is, .not clear. To study this problem 
it was necessary to establish a sensitive bioassay for gastrin-like 
activity and in 1976 Dr. Beverly Napier travelled to London to 
learn the technique of the cytochemical bioassays in Dr. J. Chayen's 
laboratory at the Kennedy Institute. Thus, when I joined the group 
in 1977 my aim was, in collaboration with Dr. Napier, to establish 
a cytochemical section bioassay for gastrin, to measure the 
biological activity of gastrins in serum and to compare these with 
the immunoreactive gastrins, the purpose being to explain some of 
the discrepancies between acid secretion and serum gastrin levels 
which had previously been widely reported. 
Acid secretion, however, is a complex process involving neurocrine, 
paracrine and hormonal mechanisms. There are at least three major 
acid secretagogues, of which gastrin is one, and in addition 
several putative physiological acid inhibitors. 
10 
These secretagogues and inhibitors interact on the parietal cell 
to cause, in some cases,potentiating effects (Soll 1978b) and as 
such, the role of an individual substance such as gastrin becomes 
all the more complicated. 
It became obvious that the measurement of bioactive . gastrins 
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in serum was not possible as long as the biological end-point of the 
assay, namely the parietal cell was also under non-gastrin influences. 
Serum therefore contains "CA stimulatory activity" (CASA) of which 
doubtless, gastrin is a major, but not the only component. We neverthe-
less measured the CASA of serum in normal subjects, after a mixed 
meal and in hypergastrinaemic states and these results have been 
reported in this work. 
However,the findings that the parietal cells in this system responded 
to all three major secretagogues led this work in a different 
direction. The discovery of the histamine H2
-receptor blockers by 
Black and his colleagues (Black, Duncan et al, 1972) and the findings 
that these agents significantly reduced acid secretion induced by all 
agents has led to renewed interest in the mechanisms of secretagogue 
interactions at a receptor level, and their mechanisms of action 
within the parietal cell. It became apparent that the technique of 
the cytochemical bioassay provided a unique model of parietal cell 
activation and the remainder of this work discusses tpe initial 
findings in this field. 
This work therefore consists of three sections. Section A is a 
literature review in which the control of acid secretion by the 
four mechanisms, neurocrine, endocrine, paracrine and luminal 
factors is discussed, with special emphasis on gastrin, histamine 
and acetylcholine. 
In addition, the mechanism of secretion of acid by the parietal 
cell has been briefly discussed with a special emphasis on the 
role of carbonic anhydrase (CA) in parietal cell function. 
Section B includes the methods established for measuring CA 
activity in parietal mucosal sections by quantitative cytochemistry 
and the validation . of these measurements. 
This is followed by the effects of the three secretagogues on CA 
activity, their interactions, inhibition by the histamine H2-
receptor blocker cimetidine and the anticholinergic agent atropine 
and the effects of lanthanum chloride on secretagogue function. 
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Section C includes the cytochemical bioassay for CASA in serum of 
normal subjects, both fasting and postprandial and in hypergasirin-
aemic patients and the comparison with the radioimmunoassay for 
gastrin. This is followed by a summary of findings and the appendix 
in which the method of radioimmunoassay for gastrin, and statistical 
methods are discussed. 
SECTION A: LITERATURE REVIEW 
CHAPTER 2 ACID SECRETION IN THE STOMACH 
INTRODUCTION 
The secretion of acid by the upper gastrointestinal tract first 
appears among the lowest vertebrates on the phylogenetic tree and 
has since been retained by most species (Reite 1972). 
The major physiological role for this acid seems to be in the 
facilitation of protei~ digestion by pepsin while other roles 
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include the promotion of iron absorption by the conversion of dietary 
iron to the absorbable ferrous form, and the sterilisation of the 
upper gastrointestinal tract (Davenport 1977). The physiological 
importance of acid-peptic digestion in man however is probably 
quite limited while the other "physiological roles" are also relatively 
non-essential. This is evidenced by the normal nutritional status 
of persons with achlorhydria. 
However, although acid secretion appears to be a dispensable physio-
logical function in man, acid does play a major role in the patho-
physiology of peptic ulcer disease and most of the bleeding 
disorders of the gastrointestinal tract. These diseases cause 
significant morbidity and .mortality wo~ld-wide. For instance, in 
male Massachusetts physicians, the lifetime prevalence of peptic 
ulcers was 7.7% (Grossman 1979a) and in the U.S.A. about 3~2,000 
cases of peptic ulcer are admitted to hospital each year. (Elashoff 
& Grossman, 1980). Furthermore the methods of treatment of peptic 
ulcers are still inadequate, in that there is a high recurrence 
rate after both medical and surgical treatment. This is partially 
due to inadequate understanding of the pathophysiology of this 
group of diseases. 
In order to develop more rational forms of treatment, and to 
initiate appropriate preventative measures for the development of 
peptic ulcers, we must acquire a far greater understanding of the 
physiology of acid secretion. This includes its regulation, ionic 
fluxes across the mucosa! barriers and the cellular physiology and 
biochemistry of the parietal cell per se. 
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This section reviews current knowledge on aspects of control and 
mechanisms of acid secretion with special reference to gastrin, 
histamine, acetylcholine and the role of carbonic anhydrase in acid 
secretion. The review includes literature published before July 1980. 
CHAPTER J 
.l.:._! Anatomy of the Parietal Mucosa 
The enzymes and hydrochloric acid secreted in the stomach are mainly 
produced in the glands of the mucous membrane of the fundus and body 
of the stomach. The anatomy of these glands differs to some extent 
between species. 
In the human the glands extend from the bottom of the gastric pits 
or foveolae, which appear like tiny openings in the gastric mucosa 
to the muscularis mucosa. They are straight most of their length 
but become tortuous near the muscularis mucosa. Each tubular gland 
consists of three segments; the deepest point is the base, the 
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middle part is the neck and the upper part is the isthmus which is 
continuous with the pit. Several glands may open into a pit.(Fig. J:1). 
The glands contain four main types of secreting cells. The isthmus 
contains both surface epithelial cells, which secrete mucous, and 
parietal cells which secrete acid. The latter are large cells and 
have relatively clear cytoplasm stained by PA Schiff and haematoxylin 
methods. (Fig. J:2}. They vary from round to triangular in shape and 
have dark centrally placed nuclei. (Fig. J:2). The size varies from 
10-16µ in diameter. The neck of the gland is made up chiefly of 
cells known as mucous neck cells. These are stuffed with pink mucous 
and have a foamy appearance. The nuclei of these cells are pressed 
against their bases where they often have a more or less triangular 
shape. Individual parietal cells are scattered between groups of 
mucous neck cells. 
The base of the gland is made up mostly of zymogen (chief) cells. 
These have accumulations of basophilic material in their cytoplasm 
near their bases and produce pepsin. 
The parietal cells are scattered among the zymogen cells. The guinea 
pig differs from the human in that the parietal cells are far more 
evenly distributed throughout the gland with a number apparent in 
both the base and neck area of the glands. 
J: 2 The Fine Structure of the Parietal Cell (Lentz 1971) 
Parietal cells are pyramidal or triangular in shape. The striking 
morphological specialization of this cell is secretory canaliculi 
that ext e nd from the apex of the cell and pass lateral to the nucleus, 
almost to the base of the cell. Numerous microvilli extend into the 
lumen of the canaliculus. The canaliculi open into a common outlet 
that is continuous with the lumen of the gland. Thus the extensive 
surface area of the canaliculus is exposed to the glandular lumen. 
Microvilli also occur on the surface of the common opening and apical 
region of the cell. The lateral surfaces are relatively smooth in 
contour but the basal surface is thrown into villi or plications. 
Another unusual feature of this cell is an extensive system of 
cytoplasmic tubules limited by smooth membranes. These tubules may 
be continuous with the canaliculi in places, in which case they may 
be regarded as complex invaginations of plasma membrane rather than 
the smooth-surfaced endoplasmic reticulum. Mitochondria are 
relatively large, numerous and spherical or oval in shape. Cristae 
are closely packed and transverse over half the width of the 
organelle. Lyosomes are present as well as a few short cisternae of 
rough surfaced endoplasmic reticulum. Free ribosomes occur in the 
cytoplasm and a small Golgi apparatus near the base of the cell. 
16 
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FIG. 3: 1 Human Gastric Mu~osa --------
a) Gastric pit 
b) Neck of gland 
c) Muscularis mucosa 
d) Surface epithelium 
X 60 Haematoxylin and Eosin 
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FIG. 3:2 Human Fundic Mucosa 
0 Oxyntic/parietal cell 
z Zymogen/chief cell 
s Surface epithelium 
X 150 Haematoxylin and eosin 
CHAPTER 4 
THE REGULATION OF GASTRIC ACID SECRETION 
The regulation of acid secretion ranks as one of the most complex 
physiological processes in the body. The physiological stimulus for 
the secretion of gastric acid is the ingestion of food and the 
response of gastric acid secretion to food can be divided into 
three phases. Firstly the cephalic phase which may occur in 
anticipation of eating, secondly the gastric phase which occurs 
when food reaches the stomach and lastly, the intestinal phase of 
acid secretion. (Davenport 1977). At the cellular level however, 
acid secretion during all three phases may be considered to be the 
result of four main regulatory pathways with both stimulatory and 
inhibitory components. 
4:1 The Four Pathways to the Parietal Cell 
All bodily processes, including gastric acid secretion are regulated 
by chemical messengers which originate in cells responsive to 
alterations in the environment. These are delivered to target cells 
• 
by one of three modes; neuronal, endocrine or paracrine. (Soll and 
Grossman 1978). In response to a physiological stimulus such as a 
meal, the parietal cell is directly or indirectly regulated through 
each of these pathways. (Soll & Grossman 1978). In addition, recent 
studies indicate that in the gut, luminal contents may also have a 
direct effect on target parietal cells. (Debas and Grossman 1975). 
The relative importance of each of these pathways in determining 
the integrated response of the parietal cells to a meal is not yet 
known. It is likely that these four pathways will not have the same 
functional inter-relationships under all physiological situations 
and in all species. 
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Lastly, it is interesting from a teleological point of view that 
acid secretion, a function which is apparently physiologically 
dispensible, is under such redundancy of control. 
4: 2 The Neurocrine Pathway of Acid Secretion 
Neuronal or neurocrine effects can directly activate the parietal 
cell to secrete acid by release of acetylcholine and other neuro-
transmitters from post-ganglionic nerve endings. 
The neuronal path can be activated both by vagal efferent fibres 
and by local reflex arcs within the wall of the stomach. (Debas 
1977). Cephalic phase stimuli act solely through vagal efferent 
fibres, whereas gastric distension can act both through vasovagal 
reflexes and also somewhat less efficiently through local reflex 
arcs. (Soll and Grossman 1978). The effects mediated by both 
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vagal efferent fibres and local reflex arcs are inhibited by 
muscarinic cholinergic antagonists such as atropine. The view that 
the post-ganglionic neuronal pathway utilises cholinergic transmitters 
is further supported by observations in laboratory animals that 
exogenous cholinomimetic drugs such as carbachol produce the same 
maximum response as vagal stimulation, gastrin or histamine. In 
man however, there is only a small response to these drugs, (Roland, 
Berstad et al, 1975) highlighting the wide variability between 
species in the regulation of gastric acid secretion. It is possible 
that in man there are also cholinergic inhibitory pathways or 
non-cholinergic vagal efferent fibres. (Soll and Grossman, 1978). 
The release of gastrin too, is in part under neuronal control. 
In fact,each of the mechanisms described for neuronal activation 
of the parietal cell can also cause neuronal release of gastrin. 
However, the administration of exogenous cholinomimetic drugs 
causes little or no release of gastrin and atropine often enhances 
rather than inhibits gastrin release. (Walsh and Grossman, 1975). 
Thus it is possible that vagal release of gastrin is non-cholinergic 




Although acetylcholine is the only known neurocrine stimulator of 
acid secretion there are a number of peptides recently isolated in' 
gut which are also present in brain and may have neuro-modulatory 
actions. These include somatostatin (Polak, Grimelius et al 1975, 
Brownstein, Arimura et al 1975), vaso-active intestinal peptide, 
(V.I.P.) (Bryant, Polak et al 1976, Larsson, Fahrenkrug et al 1976), 
substance P (Pearse: and Polak 1975), (Nilson, Larsson et al 1975) 
neurotensin (Polak, Sullivan et al 1977a), the endorphins and ·· 
encephalins (Hughes, Smith et al 1975, Polak, Sullivan et al 1977b) 
and cholecystokinin (CCK) (Rehfeld 1978). In addition, V.I.P., 
substance P, the encephalins (Lundberg, Hokfelt et al~ 1979)gastrins 
(Uvnas Wallensten, Rehfeld and Uvnas 1977), and somatostatin (Uvnas 
Wallensten, Efendik and Luft 1978), are present in the vagus and 
V.I.P., substance P (Polak and Bloom 1978) and CCK tetrapeptide 
(Larsson and Rehfeld 1979) have been isolated in the autonomic nerves 
of the gut. As V.I.P. and somatostatin are known inhibitors of 
acid secretion, it is conceivable that these may act as neurocrine 
inhibitors, whereas encephalins and CCK may act as neurocrine 
stimulators. This is however still speculative and the physiological 
functions of all these gut-brain peptides is still unknown. 
Other known neurotransmitters which may act as inhibitors of acid 
secretion via a neurocrine pathway include dopamine (Valenzuela 
1976) and serotonin (Jaffe, Kopen and Lazan 1977). 
4: 3 The Paracrine Pathway of Acid Secretion 
Paracrine secretion refers to diffusion of a chemical messenger 
from its cell of origin across inter-cellular spaces to its target 
(Creutzveld 1976). Both the concept of paracrine secretion and its 
potential role in the secretion of acid remain hypothetical. There 
is however little doubt that histamine secreted locally from 
mucosal stores has a major effect on parietal cell function and it 
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is of interest that histamine appeared in the upper gastrointestinal 
tract at the same point in the phylogenetic tree that the ability 
to secrete acid was acquired (Reite 1972). Histamine is present in 
large quantities, about 40µ g/ gram wet weight in the parietal 
mucosa of hum a ns and other mammals (Reite, 1972, Troidl, Lorentz 
et al, 1975). While histamine is the major paracrine secretagogue 
postulated, it is now becoming apparent that there are several 
substances which inhibit acid secretion which may have a physio-
logical role, acting via the paracrine pathway. These include the 
prostaglandins, a group of ubiquitous compounds synthesized from 
fatty acid precursors which exhibit a variety of biological functions, 
including the inhibition of gastric acid secretion (Robert, Nezamis 
and Phillips, 1968). Prostaglandins of the A and E series are 
synthesized in the gastric mucosa and are secreted into gastric 
juice under basal and stimulated conditions. Their physiological 
role in acid secretion is unknown but they have, in addition to 
acid inhibition, been postulated to be cytoprotective · to the gastric 
mucosa, an effect not entirely accounted for by their effects on 
acid secretion (Chaudbury and Jacobson, 1978). 
Another substance which may act via the paracrine pathway is 
somatostatin. In the pancreas the somatostatin D-cells are found 
in the islets adjacent to the insulin-producing B-cells and the 
glucagon A-cells. It has been postulated by Unger and Orci (1977) 
that somatostatin acts as a paracrine substance within the islet, 
to regulate insulin and glucagon responses to absorbed nutrients. 
Somatostatin, which inhibits both gastrin release and acid secretion 
directly (Bloom, Mortimer et al, 1974), is found in high concent-
rations in the antrum (Kronheim, Berelowitz and Pimstone, 1976). 
It has been suggested that it may inhibit gastrin secretion in an 
analogous manner to its suggested mode of action in the pancreas. 
The mechanism of action of somatostatin on the parietal cell per se 
or even whether this occurs under physiological conditions is still 
unknown. 
While the roles of the candidate paracrine acid inhibitors are still 
obscure, the emergence of histamine as a prime acid secretagogue 
has, with the development of the histamine H
2
-receptor blockers, 
become increasingly evident. (Black, Duncan et al, 1972). This 
substance will therefore be reviewed in greater detail. 
4: J: 1 Histamine as an Acid Secretagogue 
4: J: 1: 1 History: 
Histamine was discovered in 1907 when it was synthesized by Windhaus 
and Vogt. It was first isolated from intestinal mucosa in 1911 
(Barger and Dale) but was only found to stimulate gastric secretion 
in 1920 by Popielski. 
4: J: 1: 2 Chemistry: 
Histamine has a single chemical source. It is derived from histidine 
by the action of the enzyme histidine decarboxylase. 
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This enzyme is easy to demonstrate in the gastric mucosa of a rat 
in which the activity is exceptionally high. However, in all other 
species the activity of this enzyme is low and diffi c ult to detect 
(Code, 1977). Histamine is very rapidly inactivated- This occurs 
through one of two mechanisms; either by deamination of the side 
chain with the enzyme diamine oxidase or by methylation of the 
nitrogen of the imidazole ring with the enzyme N-methyl transferase. 
These enzymes are present both in serum (Beaven and Schaff, 1975) 
and in tissue (Baylin, Beaven et al, 1972). Code (1977), has said 
that the inactivation of histamine is "explosive". Thus histamine 
is not normally detected in serum of guinea pigs, cats, dogs or 
humans (Beaven, Jacobsen and Horakova, 1972). These workers used 
an assay with a lower limit of sensitivity of approximately 2nM 
Small concentrations were noted in rat blood, and the mast cell 
histamine releaser compound 48/80 increased the histamine in rat 
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serum. However, extracts of most tissues contain measurable histamine 
concentrations (Beaven, Jacobson and Horakova, 1972). 
4: J: 1: J Cells of Origin: 
Although histamine is present in the gastric mucosa of most species 
tested, including man (Code, 1956) the cells of origin have been 
difficult to identify and characterise. There appear to be inter-
species differences and there is some evidence in animals other 
than the rat, that histamine is contained in a cell that is morpho-
logically indistinguishable from a mast cell. Further evidence for 
this has been provided by Soll, Lewin and Beaven (1979). However, 
gastric histaminocytes are physiologically quite distinct from peri-
vascular mast cells - for example perivascular mast cell histamine, 
but no gastric mucosa! histamine is released by compound 48/80 and 
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by antigen-antibody reactions, whereas gastric histamine mobilization 
is under an entirely differe nt set of controls. Soll, Lewin and 
Beaven (1979) have suggested that in dog, histamin e containing cells 
are situated in the lamina propria in close proximity to the gastric 
glands. However, whether these cells are activated by compound 
48/80 or whether they control gastric acid secretion has not yet 
been demonstrated. 
4: J: 1: 4 Mechanisms of Gastric Histamine Mobilisation 
The mechanism controlling the release of gastric histamine and the 
pathways leading to the formation of gastric histamine stores remains 
unknown. Much of the experimental data in this field has been 
gathered in rat models. One of the reasons for this is that histidine 
decarboxylase activity is easily measurable in rats, as it is about 
1 000-fold higher than in most other species (Code, 1977). Thus it 
may be incorrect to extrapolate these findings to other species. 
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In 1938 McIntosh showed that histamine was present in gastric 
juice of dogs when secretion was stimulated by the direct stimulation 
of the vagus or by psychic stimulation. Emmelin and Kahlson (1944) 
confirmed this, while Code, Hallenbeck and Gregory (1947) found 
that histamine is present in gastric juice of dogs during their 
response to a meal of meat. The histamine output occurs during the 
early phases of gastric secretion. · Hilland Code (1959) showed 
that vagal stimulation in dogs caused accumulation of histamine in 
the gastric mucosa, as if vagal stimulation had increased its 
production. However as vagal stimulation is a potent releaser of 
gastrin in dogs, it is difficult to differentiate this from a gastrin-
mediated effect. 
It was subsequently shown in rats that the injection of gastrin 
(or pentagastrin) results in a lowering of gastric mucosal histamine 
content, reflecting the mobilisation of histamine (Kahlson, Rosengren 
et al, 1964, Kahlson, Rosengren and Thurnberg, 1967, Hakanson, Larsson 
et al, 1976), Furthermore, the rate of histamine formation in the 
rats' gastric mucosa was accelerated following administrati6n of 
gastrin, through the activation of histidine decarboxylase (Kahlson, 
Rosengren et al, 1964, Hakanson, Kroesen et al, 1974). Hakanson, 
Hedenbro et al (1977) suggested that vagal stimulation had an 
insignificant effect on histamine mobilisation. On the other hand 
gastrin appeared to be an obligatory intermediate of histamine 
mobilisation in rats. Hakanson, Larsson et al, (1978) also showed 
that the mobilised mucosal histamine inhibits further release of 
histamine by way of an apparent H
2
-receptor mediated auto-feedback 
mechanism in the histamine storage cells. Thus release of histamine 
in rats appears to be controlled mainly by gastrin, whereas 
inhibition of release is mediated by a bio-feedback mechanism. 
However, as has been mentioned, this cannot be demonstrated in 
any other species and the mechanism of histamine release is, in 
most species, still largely unknown. 





It had been known for some time that although certain effects of 
histamine, such as the stimulation of contraction of smooth muscle, 
could be blocked by the antihistaminics such as mepyramine, these 
27 
drugs had no effect on acid secretion. Thus, two types of histamine 
receptors appeared to be present - the H
1
-receptor which was mepyramine 
sensitive and the H
2
-receptor which was not. 
In 1972, Black, Duncan et al discovered a specific antagonist of the 
H
2-receptor. The first substance synthesized with these properties 
was burimamide. The subsequent substance developed, metiamide, was 
4 . to 6 times as potent as burimamide but the occurrence of granulo-
cytopaenia in a small number of patients limited its use. Cimetidine, 
the newest H
2
-receptor blocker synthesized, is free of this side-
effect and has been successfully marketed in this country for the 
treatment of duodenal ulceration. Cimetidine is an effective 
inhibitor of both basal acid secretion as well as histamine and 
pentagastrin-stimulated secretion (Richardson, 1978). It is 
generally less active against cholinergically stimulated secretion 
but does have some inhibitory effect (Brimblecombe, Duncan et al 
1978). Thus it appears that a specific H
2
-receptor antagonist has 
a rather non-specific effect on acid secretion. In order to 
understand the reasons for this, one needs to consider the inter-
actions of the acid secretagogues. The various hypotheses of acid 
secretagogue interaction will be discussed below. 
4:4 The Endocrine Pathway of Acid Secretion 
The only hormone knowri to stimulate acid secretion under physio-
logical conditions is gastrin (Walsh and Grossman, 1975). It is 
likely that another hormone is involved in the intestinal phase 
of gastric acid secretion but this has not yet been isolated 
(Grossman, Brown et al, 1974). 
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The encephalins, the natural ligands for opiate receptors, have 
recently been detected by immunocytochemistry throughout the tissues 
of the digestive system (Polak, Sullivan et al, 1977b). Konturek,' 
Pawlik et al, (1978) have shown that met-encephalin stimulates acid 
secretion. However, the mechanism by which this occurs and the 
physiological significance is still obscure, although there is some 
evidence that the encephalins may act directly on the parietal cell 
(Solomon, 1980). 
It is possible that in pathological states non-gastrin endocrine acid 
stimulators circulate in serum. Bugat, Walsh et al (1976), using 
a rat stomach bioassay, found that the serum from duodenal ulcer 
patients contained incr~ased acid secretagogue activity in the face 
of normal serum gastrins. Watson, Vinik et al, (1978) showed that 
bile duct ligation in the pig resulted in a remarkable increase in 
acid secretion in the presence of normal serum gastrins. The nature 
of these acid stimulators is unknown. 
There is evidence too, that inhibition of gastric acid secretion 
may be regulated via endocrine pathways. Acidification of the 
duodenum appears to release an inhibitory hormone which has been 
named bulbogastrone, but has not been fully identified (Andersson, 
Nilsson and Uvnas, 1967). 
Furthermore, the presence of fat in the duodenum has for some 
years been known to cause acid inhibition. This is mediated by 
a hormone called enterogastrone, but this too has not yet been 
isolated. Certain hormones which have been isolated have been 
shown to inhibit gastric acid secretion, but whether this is a 
primary physiological action of these hormones is still unknown. 
Secretin is released in response to acid in the duodenum, but the 
release of secretin during a meal is small (Schaffalitsky, de 
Muckadell and Fahrenkrug, 1978). Secretin inhibits gastrin-
stimulated acid secretion (Brooks and Grossman, 1970), but whether 
this is a physiological or pharmacological effect is still unknown. 
Similarly, gastric inhibitory polypeptide (G.I.P.), inhibits both 
the endogenous release of gastrin and gastric acid secretion 
(Pederson a nd Brown, 1972). This peptide was shown to be released 
in response to glucose and fats and was proposed as an entero-
gastrone (Brown, Dryburgh, et al 1975). However G.I.P. release' 
in response to fat is small and late and thus this proposal seems 
unlikely (Soll and Walsh, 1979). Vaso-active intestinal peptide 
(V.I.P.) and somatostatin which have already been discussed, 
may well yet be found to act via the endocrine pathway. 
Other peptides which have been demonstrated to inhibit acid 
secretion include glucagon (Konturek, Biernat et al, 1975), and 
calcitonin (Hesch, Hufner et al, 1971). Urogastrone or human 
epidermal growth factor, which was shown to inhibit gastric acid 
in the 19JO's (Gray, Wieczorowski and Ivy, 1939), has recently 
been localised in the Brunner's glands of human duodenum (Heitz, 
Kasper et al, 1978), and submandibular glands (Elder, Williams 
and Gregory, 1976). This substance too, is therefore a candidate 
gastric endocrine inhibitor. 
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There are thus many possible endocrine modulators of acid secretion. 
This study will deal mainly with the secretagogues, with a particu-
lar emphasis on gastrin, and its actions on the parietal cell. It 
is therefore appropriate that this group of peptides be reviewed 
in greater depth. 
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4: 4: 1 The Gastrins 
4:4:1:1. History: 
In 1905, the year that Starling introduced the word 11 hormone 11 to 
designate a class of chemical messengers which may be released by 
one part of the body and control activities in a different part 
of the body, Edkins announced that extracts of antral mucosa 
stimulate acid secretion when injected intravenously into anaes-
thetised cats. He named the active principle Gastrin. However, 
his extracts contained histamine as well as gastrin and for many 
years a controversy raged over whether they contained a stimulant 
other than histamine. 
In 1938, Komarov produced histamine-free extracts that still 
stimulated acid secretion, but a number of workers could not verify 
this finding. Thus the controversy was still not resolved. All 
doubt was dispelled in 1964 when Gregory and Tracy isolated pure 
gastrin from hog antral mucosa and with Kenner and co-workers 
determined its structure (Gregory, Hardy, et al 1964) and synthe-
sized it (Anderson, Barton et al, 1964). 
4: 4: 1: 2 Chemistry: 
The compounds isolated from hog antral mucosa by Gregory and Tracy 
were heptadecapeptides. Two species were found; one form was 
sulphated on the tyrosine residue in position 6 from the carboxy-
terminal and was named Gastrin II; the other form was non-sulphated 
(Gastrin I). In all other respects the two species were identical. 
Gastrin heptadecapeptides have been purified from antral mucosa 
of several species including man, (Bentley, Kenner and Sheppard, 
1966) pig, cat, sheep and cow and found to differ by only one or 
two amino-acids in the middle of the linear peptide chain (Kenner 
and Sheppard, 1973). 
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In 1970, Yalow and Berson described a larger molecular form of 
gastrin and named it "big gastrin 11 • Big gastrin has been 
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purified from human gastrinoma extracts (Gregory and Tracy, 1972) 
and from hog antral mucosa. The amino-acid sequences have been 
determined by Gregory and Tracy (1974a). Big gastrin (abbreviated 
in terminology to G34), contains 34 a~ino-acids. By convention 
the amino-acids of gastrins are numbered from the amino-terminal. 
Of the 34 amino-acids, residues 18-34 are identical to the gastrin 
heptadecapeptide (G17). (Table 4:1). 
Subsequently, minigastrin (G14), identical to residue 21-34 of G34 
or 4-17 of G17 was isolated in the serum of a Zollinger-Ellison 
syndrome patient (Gregory and Tracy, 1974b). Thus the carboxy-
terminal, which is the biologically active portion of the molecule, 
is common to all three forms of gastrin, G34, G17 and G14. All 
occur in both sulphated and non-sulphated forms, usually in approx-
imately equimolar quantities. Tridecapeptide, amino-terminal of 
G17, has also been identified in the serum and mucosa! extracts 
of a patient with gastrinoma (Dockray and Walsh, 1975). This was 
biologically inactive. Furthermore, large quantities of N-terminal 
material has been found in the sera of several normal patients 
(Malagalada, 1978a). 
Recently Rehfeld and Larsson (1979), have suggested that the 
gastrin found in the largest molar quantities in gut is the carboxy-
terminal tetrapeptide, which is common to both cholecystokinin' 
and gastrin. This has been designated CCK4 and is apparently 
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Other forms of gastrin have been found in tissues in the circula-
tion. Two of these are big-big gastrin (BBG) of Yalow and Berson 
(1972), and component I of Rehfeld (Rehfeld, Stadil and Vikelsoe, 
1974). There is controversy over the existence of these forms, 
which emerge from Sephadex gel-filtration columns with high 
molecular weight material. Although it has been suggested that 
(BBG) constitutes a major fraction of plasma gastrin in normo-' 
gastrinaemic subjects, Rehfeld, Schwartz and Stadil (1977), main-
tained that BBG is not a true entity in normal serum but is 
attributable to interference in the gastrin assay by normal serum 
proteins. There is however, no doubt that in certain gastrinoma 
patients, gastrin macromolecules, consisting of G17 covalently 
coupled in its amino-terminal to proteins of varying length, do 
exist. The biological activity of these large molecular weight 
gastrins is unknown. 
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Studies of protein biosynthetic mechanisms have shown that peptide 
synthesis proceeds from N-terminal to C-terminal amino-acid 
(Habener and Potts, 1978). It thus seems likely that gastrin is 
synthesized as the 34-amino-acid, big gastrin, or a larger molecule 
and then converted enzymatically into the heptadecapeptide and 
other smaller gastrin fragments. Recently a preprohormone form of 
gastrin consisting of 110-140 aminoacids has been postulated 
following detection and partial sequence analysis of ga~trin 
messenger RNA (Noyes, Mevarech et al, 1979). In this way gastrin 
appears to resemble other hormones such as insulin (Steiner and 
Oyer, 1967), glucagon (Tager and Steiner, 1973) and parathyroid 
hormone (Habener, Kemper et al, 1975). There is as yet no evidence 
for conversion of GJ4 to G17 in the circulation and the conversion 
seems likely to occur in the G cell. 
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Internal cyclization of the N-terminal glutamic acid residue leads 
to the formation of a pyroglutamyl group in GJ4 and G17 and prevents 
digestion by aminopeptidases. 
All known forms of gastrin are linear peptides that contain no 
sulphide bonds. At neutral pH G17 exists as random coils but at pH 
less than 4.5 the five glutamic residu e s form an alpha helix. 
(Piskiewicz, 197'*). 
'*: '*: 1: 3 Structure-Activity Rela t ions 
The carboxy-terminal portion of the gastrin molec ul e h as all the 
biologic actions of the whole molecule (Tracy and Gregory, 1964). 
Traces of activity are seen with fragments as small a s a C-terminal 
dipeptide amid e . The tripeptide amide has di s tinct act ivity 
(Lin, 1972) and the tetrapeptide amid e is about one sixth as potent 
as G17 on a molar basis. Re mov a l of the C-te rminal amid e to form 
the free acid results in complete loss of activity but one of the 





loss of activity (Morley, 1968). 
Pentagastrin is a commercially availabl e synthetic pentapeptide 
consisting of the C-terminal tetrapeptide amide of gastrin plus 
beta-alamine and an N-terminal blocking group (tertiary-butyl-
oxycarbonyl). Its potency is comp a r a ble to that of the C-terminal 
pentapeptide of gastrin. Expressed in terms of exog e nous dose 
needed to give a certain fra c tion of maximal response, molar 
potency increases with chain length from G1'* to GJ4. (Walsh, 
Debas and Grossman, 1974, Debas, Walsh and Grossman, 197'*a, 
Walsh, Isenberg et al, 1976). 
Expressed as a blood level needed to give a certain fraction of 
maximal response, G17 is six times more potent on a molar basis 
than GJ4 (Walsh, Isenberg et al, 1976), and equal in potency to 
G14 (Carter, Taylor, et al 1979). The half-life disappearance 
time of G17 after intravenous infusion in human subjects is 5 to 
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6 minutes (Walsh, Isenberg et al, 1976). The half-life disappearance 
time of G14 in dogs is 2.8 minutes, which did not differ signifi-' 
cantly from that of G17 (1.7 mins.) (Carter, Taylor et al, 1979). 
This has not yet been confirmed in humans. 
Walsh, Isenberg et al (1976), showed that after stimulation of 
gastrin release by the instillation of a peptone solution into the 
stomach, G34 comprises about 75% of the total molar concentration 
of circulating gastrins. However, considering the differences in 
potency and half-life disappearance times of GJl~ and G17, they 
calculated that GJ4 contributes less than 50% of the acid stimulatory 
activity. More recently however, Taylor, Dockray and Walker (1979) 
estimated that about 50% of the increase in serum gastrin after a 
meal was due to G17, whilst Lamers, Harrison et al (1979) reported 
that the levels of G34 double, whereas G17 quadruples after a meal, 
to end up with a ratio of 1:1; In 1978 Feldman, Walsh et al, using 
a specific anti-G17 antiserum showed that the gastrin-induced acid 
secretion, in response to an intragastric peptone infusion could 
be entirely accounted for by G17 release only. The reasons for these 
discrepant findings were not discussed, but it is possible that 
the circulating gastrins do not have their expected biological 
activities. 
It appears that gastrin and cholecystokinin have developed in 
evolution from a common precursor molecule. The C-terminal penta-
peptide amide sequence of both molecules are identical and this 
fragment has all the biological actions of both hormones. 
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The crucial difference between gastrin and cholecystokinin (CCK) 
is the location of the sulphated tyrosine residue. In gastrin 
it is in the position 6 from the c-terminus, while in CCK it is 
is position 7. In CCK this fragment is, unlike gastrin, always 
sulphated. Removal of the sulphated group causes it to revert to 
a gastrin-like pattern of activity. CCK-like peptides, that is 
those with sulphated tyrosines in position 7, have high relative 
potency for gall bladder contraction and pancreatic enzyme secretion 
and lower relative potency for gastric acid secretion. The C-
terminal heptapeptide amide of CCK is the smallest fragment that 
shows the CCK pattern of preferential potency on gall-bladder 
and pancreas (Ondetti, Rubin et al, 1970). This heptapeptide 
fragment is more pot e nt on a molar basis than whole CCK but the 
ratio of its potency for the gall bladder and pancreas to its 
potency on acid secretion is not as great as that of whole chole-
cystokinin. Thus, whereas the octapeptide fragment of the hormone 
and the related peptide caerulein have a very high potency for 
gall bladder and pancreas, they do not have the degree of specificity 
for these organs that whole CCK has. Among the gastrin-like 
peptides the ratio of potency for gall bladder and pancreas to 
potency on acid secretion does not vary with chain length, being 
essentially constant for G14 through GJ4. 
Cholecystokinin-like peptides stimulate acid secretion in all 
species, but in some species (rat, cat) they are full agonis'ts 
(i.e., the maximal response is as great as to gastrin) whereas in 
others (man, dog) they are partial agonists, producing maximal 
responses about one fifth as great as gastrin (Johnson and Grossman, 
1971). 
4: 4: 1: 4 Distribution of Gastrin 
The cells that contain gastrin in the gut are called G cells and 
are found in the pyloric glands of the distal stomach (antrum) 
and the proximal duodenum (McGuigan and Greider, 1971). About 5 
to 50 µg G17 can be recovered from boiling water extracts per 
gram of antral mucosa. G34 and other molecular variants represent 
less than 10% of antral gastrin content (Berson and Yalow, 1971). 
In proximal duodenum the gastrin concentration is 10 to 50% of 
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that in antral mucosa but in view of the greater bulk of duodena~ 
mucosa it has been estimated that the total duodenum content may 
be similar to the antral content (Nilsson, Yalow and Berson, 1973). 
Lower concentrations of gastrin are found in the distal duodenum 
and jejunum. 
The duodenal gastrin is made up predominantly of G34 (Berson and 
Yalow, 1971). Small amounts of human gastrin have been extracted 
from human pancreas by some workers but this has not been confirmed. 
Gastrin has also been identified in the pituitary gland (Rehfeld, 
1978), while the gastrin-like peptide described in brain 
(Vanderhaeghen, Signeau and Gepts, 1975) has been identified as 
cholecystokinin-octapeptide (Dockray, 1976). In the serum, the 
predominant gastrin that is present in the fasting state is BBG 
(Yalow and Wu, 1973), although this is disputed by Rehfeld, Schwartz 
and Stadil (1977). In fed normal subjects, or hypergastrinaemic 
patients (e.g., those with gastrinomas or pernicious anaemia) G34 
is the predominant circulating form comprising 70 to 90% of total 
immunorea~tivity, (Walsh ~nd Grossman, 19j5).In gastrinoma patients,· 
as has beeri discussed, many other gastrin variants are found in 
serum. 
4: 4: 1: 5 The Release of Gastrin 
As with acid secretion, gastrin secretion is mediated via 
several pathways. These too, include endocrine, neurocrine, 
luminal and paracrine pathways. However, in the case of gastrin 
the luminal pathway tends to predominate and amino-acids in 
the chyme which bathes the microvilli at the luminal surface of 
the G-cells are the most potent releasers of gastrin (Richardson, 
Walsh et al, 1976, Walsh, Isenberg et al, 1976, Richardson, Walsh 
et al, 1977). 
Strunz, Walsh et al (1978a), showed that the release is stimulated 
chiefly by four amino-acids, namely cysteine, phenylalanine, tryp-
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tophan and hydroxyproline. Konturek, Tasler et al (1977) in contrast 
found that phenylalanine was a weak releaser of gastrin, whereas 
serine, valine and tryptophan caused greater release. The reason 
for this discrepancy is unknown. Glucose and fat release 
gastrin but at much lower levels. 
Inhibition of gastrin release occurs where the pH of the stomach 
lumen falls. At a pH of 1.0 maximal suppression of gastrin 
release occurs while even at a pH of 2.5,gastrin release in 
response to a meal is reduced. (Walsh, Richardson et al, 1975). 
In contrast long term hypo- or achlorhydria is a stimulant to 
gastrin release. Thus in atrophic gastritis and pernicious 
anaemia there is a m~rkedly elevated fasting serum gastrin, 
with excessive release after food. 
The neurocrine pathway to gastrin secretion is mediated via the 
vagus. Vagal excitation in dogs by sham feeding (Nilsson, Simon 
et al, 1972 , Tepperman, Walsh and Preshaw, 1972) or insulin 
hypoglycaemia (Csendes, Walsh and Grossman, 1972) stimulates the 
release of gastrin from the G-cells. This release is abolished 
by vagotomy . Atropine enhances the serum gastrin response to 
food in low doses but in high doses blocks the response 
( Impicciatore, Walsh and Grossman, 1977). In man the cholinergic 
control of gastrin secretion is of much less importance than the 
dog. Sham feeding in man causes a slight rise in serum gastrin 
(Richardson, Walsh et al, 1977), while gastric distension has no 
effect (Idem). 
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The endocrine and p a racrine pathways to gastrin release are less 
well defined. Blood-borne stimulants include calcium (Reeder, 
Becker and Thompson, 1974 , Christiansen, 1974) epinephrine (Stadil 
and Rehfeld, 1973), and parathyroid hormone (Bolm a n , Cooper et al, 
1977), but these only appear to act as gastrin releasers in 
pathological situations such as parathyroid a denom a s (Christiansen, 
1974) or ph a eo c hromocytomas (Hayes , Ardill et al, 1972). 
Bombesin, a peptide isolated from frog skin, releases antral 
gastrin when injected intravenously in man or dog (Bertaccini, 
Melchiori et al, 19 74). This peptide has recently been shown to 
be present in endocrine cells of the duodenum (Polak, Ghatei et al 
1978) and may play a role in the release of gastrin by an endo-
crine route. All the peptides which have been shown to inhibit 
acid secretion also inhibit gastrin release. These include the 
four chemically related peptides, glucagon (Becker, Reeder and 
Thompson, 1973) secretin (Thompson, Reeder et al, 1972), V.I.P 
and G.I.P. (Pedersen and Brown, 1972) as well as calcitonin 
(Becker, Reeder et al, 1974, Bolman, Cooper et al, 1977) and 
somatostatin (Bloom, Mortimer et al, 1974; Barros D'sa, Bloom 
and Baron, 1978}. However, whether these are pharmacological 
effects or whether they modulate gastrin release physiologically 
via the endocrine or paracrine pathway is still unknown. 
4:4:1:6: The Target 
Gastrin when injected intravenously, has a wide range of effects 
ranging from water and electrolyte secretion in the small bowel 
and pancreas to stimulation of the smooth muscle of the gall-
bladder (Walsh and Grossman, 1975}. Most of these effects are 
probably pharmacological. The primary physiological effect of 
gastrin is unquestionably the stimulation of acid secretion, but 
the manner in which this is achieved is still controversial. 
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Peptide hormones usually act at membran e -bound receptors, and 
gastrin is probably no exception. Gastrin binding has been 
demonstrated on gastric plasma membranes (Lewin, Soumarmon et al, 
1976, Brown and Gallagher, 1978} and binding to isolated parietal 
cells of guinea pig (Del Mazo and McGuigan, 1976} and rat (Soumarmon, 
Cheret and Lewin, 1977} has been described. However, all these' 
workers have failed to demonstrate biological specificity and 
sensitivity and their findings to date remain controversial (Soll 
and Grossman, 1978}. Takeuchi, Speir and Johnson (1979a, b, 1980} 
have recently described an improved membrane preparation which' 
satisfies some of the criteria for hormone receptor interaction. 
Using an auto-radiographic technique, Salgalnik, Bersimbaev et al, 
(1976), have shown binding of labelled (JH)-pentagastrin to the 
histamine producing q-like endocrine cells and chief cells, 
rather than to 
the parietal cells in rats, while Hedenbro, Fink and Fiddian-
Green (1978 a,b) have demonstrated by immunofluorescence Leu-
gastrin binding to the luminal surface of the parietal cells. 
Recently it was demonstrated that insulin has in addition to 
membrane receptors, intracellular binding sites. Kirsch, Vinik 
et al (1975) have demonstrated gastrin binding to the cytosol 
fraction of liver homogenate, so the possibility of gastrin 
having intracellular binding sites also arises. However, 
demonstrating that a hormone will bind to a particular cell or 
cellular constituent per se is not sufficient evidence that the 
binding represents occupation of a receptor by the hormone. 
Even .if it is established that hormone binding correlates with 
changes in some cellular biochemical reaction, it c a nnot be 
assumed that this reaction is a reflection of the interaction 
of the hormone with th e same receptor that causes the hormone 
response, until it has been established that the change measured 
is an integral step in the sequence of events leading to the 
hormone response. Thus in the case of gastrin, where the 
sequence of events leading to acid secretion is still unknown, 
the importance of the demonstration of gastrin-binding to various 
cell~ and cell components has yet to be shown. 
4:5 The Luminal Pathway of Acid Secretion 
Debas and Grossman (1975) showed that protein digests stimulated 
acid secretion when instilled into isolated denervated fundic 
(Heidenhain) pouches. This was independent of gastrin release. 
Konturek, Tasler et al (1977), showed that amino-acids phenyl-
alanine, alanine and glycine were the most potent in stimulating 
acid secretion, although they were weak releasers of gastrin. 
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The L-isomers of all the amino-acids tested produced acid 
secretion, although certain of these amino-acids were potent 
releasers of gastrin. Undigested protein such as serum 
albumin does not stimulate acid secretion (Debas and Grossman, 
1975). 
Gastrin and other gut hormones may also act via the luminal path~ 
way. Knight, Fiddian-Green and Vinik, (1978) showed that gastrin 
was released into gastric juice in response to albumin. Fiddian-
Green, Farrel et al,(1978) also showed that gastrin added to 
neutral gastric juice stimulated a c id secretion, although this 
was disputed by Hengels, Muller et al, (1979). Lastly, Hedenbro, 
Fink and Fiddian-Gre en (1978b) have demonstrated Le u-gastrin 
binding to the luminal surface of gastric parietal c ells. 
However, whether this is biologically effective is still not clear. 
Thus the concept of luminal action of gut hormones is a novel and 
exciting but still controversial approach. 
4:6: The Interaction Between the Pathways 
The regulation of acid secretion would be adequately confusing, 
were the mechanisms enumerated acting independently. However, 
to further complicate matters, the main gastric acid secretagogues 
do not act independently but show a marked interdependence. This 
interdependence is most dramatically evidenced clinically by the 
effects of the histamine-H
2
-receptor antagonists and anticholin-
ergic agents on acid secretion. H
2
-receptor blockers such as 
cimetidine and metiamide reduce not only histamine-stimulated 
acid secretion, but also basal and gastrin or cholinergic-
mediated acid secretion. 
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Thus these agents cause a reduction in basal acid secretion · by 
about 50 to 95o/o (Sewing, Hagie et al, 1978, Richardson, 1978) 
while acid secretion in response to all other stimuli is reduced 
by 80 t~ 95o/o (Grossman and Konturek, 1974, Richardson, Bailey 
et al, 1975, Barbezat and Bank, 1978). Furthermore, anticholin-
ergic agents inhibit the acid response to histamine and gastrin 
as well as to cholinergic stimuli (Konturek, Oleksy and Wysocki, 
1968, 1 Hirschowitz and Sachs, 1969, Feldman, Richardson et al, 1977). 
Vagotomy and antrectomy are often used in surgical treatment of 
peptic ulcer disease. Each of these surgical manoeuvres alone 
inhibits th e acid response to all forms of stimulation. (Bergegardh, 
Broman et al, 1976, Konturek, Wysocki and Oleksy, 1968). Interactions 
have also been demonstrated by administering two secretagogues 
simultaneously. Johnson and Grossman (1969) showed potentiation 
of the effects of gastrin and hist a mine in dogs. However, Brooks, 
Johnson and Grossman (1970) could not demonstrate the same in man. 
Hakanson,Hedenbro et al (1977) have shown that gastrin is an 
obligatory intermediate in the postprandial mobilisation of 
gastrin histamine. This however cannot be demonstrated in other 
species (Grossman, Beaven et al, 1978). Thus the interactions 
between the secretagogues are further complicated by species 
differences. 
4: 6: 1 Theories of Secretagogue Action and Interaction 
The interdependence of the gastric secretagogues has been of 
interest to physiologists for several years. Two major theories 
have been proposed to explain secretagogue interaction. Code in 
1956 proposed that histamine acted as the final common effector 
for all secretagogues on gastric acid secretion. 
According to this theory gastrin and acetylcholine release 
histamine, which acts on the parietal cell to induce acid 
secretion. As has previously been discussed, the evidence that 
gastrin causes the release of histamine has been 
confined to the rat and has been shown in no other species to 
date. (Grossman, Beaven et al, 1978). 
A second theory i~ that proposed by Soll (1978a, b) namely that 
the parietal cell has specific receptors for histamine, gastrin 
and acetylcholine, and that potentiating interactions occur 
between these secretagogues at the parietal cell itself. Soll 
showed in a series of elegant experiments using isolated canine 
parietal cells that histamine, gastrin and carbachol (an acetyl-
choline agonist) each increased o
2 
consumption by, and (
14
c)-amino-
py'rine accumulation in the parietal cells. (Soll, 1978a, b, 1980). 
As these two indices may be regarded as indicative of acid stimu-
lation, the experiments seem to show that each secretagogue has 
an individual receptor on the cell. This theory was further 
strengthened by the use of a .histamine H
2
-receptor blocker and 
atropine which blocked the histamine and the carbachol effects 
respectively, without affecting the gastrin effect (Soll, 1978a, 
b, 1980). Soll reported histamine-gastrin potentiation as well 
as histamine-carbachol potentiation. The potentiation effect was 
blocked by the respective inhibitors, leaving a residual effect 
whfch was equal to the effect of the secretagogue alone. 
A major flaw in Soll's work is the insensitivity of the system. 
Thus gastrin only stimulated o
2 
uptake when used in a concentration 
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-7 of 10 Mand in order to bring out the differences in secretagogue 
action he found it necessary to augment the effects of the 
secretagogue by a phophodiesterase inhibitor, itself a potent 
secretagogue. 
Using histamine and isobutylmethylxanthine together with the 
gastrin, the lowest concentration of gastrin to cause an increase 
in o
2 
consumption was 1o- 10M which is the upper limit of the 
physiological range of gastrin. (Soll, 1978b). As gastrin alone 
has an effect only at 10-?M concentration, this enormous concentra-
tion of gastrin may have been causing pharmacological rather than 
physiological effect; thus it may not necessarily mean that gastrin-
mediated acid secretion occurs via the gastrin receptor on the 
parietal cell. Indeed Sonnenberg, Berglindh et al, (1979), using 
isolated rat parietal cells, could show no effect of gastrin at 
all in their system, and could offer no explanation for this 
discrepancy. Thus there are several questions still open regarding 




CELLULAR ASPECTS OF ACID SECRETION 
5: 1 Mediators of Hormone Action in the Cell 
If one assumes that the acid secretagogues act by binding cell 
membrane receptors one must postulate a "second messenger system" 
which "switches on" acid secretion. Since the discovery of 
mediation of hormone action by cyclic-AMP, there has been a great 
deal of interest in cyclic nucleotides as possible second messengers 
for the secretagogues in the parietal cell. 
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Much of the data on this is contradictory and this has been attributed 
to differences in the biological preparations that have been studied 
and the rapidly changing technology of assay procedures for adenylyl-
cyclase, cyclic-AMP and the cyclic nucleotide, phosphodiesterase. 
This was recently reviewed by Thompson, Rosenfeld and Jacobson (1977). 
They showed that in three out of four species tested, histamine 
had no effect on gastric mucosal adenylyl cyclase activity. In 
contrast, Wollin, Soll and Samloff (1979) showed that the same 
concentration of histamine which caused an increased oxygen consump-
tion in isolated canine parietal cells, caused an increase in cyclic 
AMP within these cells. Simon and Kather (1977) showed an increase 
in cyclic-AMP in human gastric mucosa in vitro in response to histamine, 
an effect which was inhibited by a histamine H
2
-receptor blocker. 
In contrast again, Levine, Schwartze! et al, (1977) failed to show 
significant increases in mucosa! or gastric juice cyclic-AMP levels 
in response to betazole, a histamine agonist. 
Recently Carlisle, Chew and Hersey (1978), showed that the changes 
in parietal cell surface membranes which accompanied acid secretion 
appeared to be dependent on c-AMP. These changes howev e r, could 
still occur in the presence of anoxia or thiocyanate which inhibits 
acid secretion. 
Before one can seriously consider cyclic-AMP as a candidate for 
mediating histamine a c tion in the parietal cell, the effects of 
secretin and the prostaglandins on cyclic-AMP production must be 
considered. Both secretin and the prostaglandins inhibit gastric 
48 
acid secretion, yet stimulate adenylyl cyclase (Thompson, Chang et al, 
1977, Dousa and Dozois, 1977) and cause a rise in cyclic-AMP 
production by unenriched isolated canine fundic cells. (Wollin, 
Soll and Samloff, 1979). Th e l a tt e r reported tha t these effects 
on cyclic-AMP production occurr e d in non-pari e tal ce lls and only 
at high con c entrations (Wollin, Soll and Samloff, 1979, Thompson, 
Chang et al, 1977). It thus remains unclear whether these effects 
are physiological or solely pharmacological. 
There are no solid candidates for the intra-cellular mediators of 
the effects of gastrin or acetylcholine. Narumi and Maki (1973) 
showed an increase in tissue cyclic-AMP in rats after stimulation 
with gastrin and carbachol. However, these agents were given in 
large doses and in addition, cause histamine release in this 
particular species. 
Nafrady and Wolleman (1977) however, showed that pentagastrin 
stimulated the adenylyl cyclase of rat stomach in the presence of 
histamine H
2
-receptor blocker. However, the data of Wollin, Soll 
and Samloff (1979) and Thompson, Rosenfeld and Jacobson (1977) are 
not in agreement with this. 
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It was suggested by Eichhorn, Salzman and Silen (1974) that the 
mediator of acetylcholine is cyclic-AMP. Griessen (1978) however, 
could not confirm this. Soll (1979) showed in his isolated canine 
parietal cell preparation that lanthanum, which displaces calcium 
from cell membranes and stops calcium fluxes across membranes 
(Hellman, Sehlin and Taljedal, 1976) and the presence of a low 
extra-cellular calcium concentration, both completely inhibited 
0 . ( 14 ) . . 1 
2 
consumption and C -am1nopyr1ne uptake in response to carbacho and 
partially in response to gastrin. This was confirmed by Sonnenberg, 
Berglindh et al, ( 1979). ++ In contrast, removal of Ca from 
histamine or dibutyryl cyclic-AMP treated cells had only slight 
effect. These studies suggest an important role for calcium in 
acetylcholine-stimulated acid secretion, possibly via an effect 
on calcium plas ma membrane pathways. 
5:2 Cytoplasmic Events during Acid Secretion 
The primary process of acid secretion is one that raises hydrogen 
ion concentrations from 0.00005 mN in the plasma to 150 - 170mN 
in gastric juice. This requires a minimum of 6.4 Kjoules/litre 
of gastric juice secreted (Davenport, 1977). The sources of 
metabolic energy for this secretion are uncertain, al though there 
is a clear increase in oxygen consumption that is proportional to 
acid secretion and activation of the Krebs tricarboxylic cycle 
(Hersey, 1974). There are conflicting studies regarding the 
source of the substrate pool. Studies in frog and rabbit gastric 
mucosa with labelled precursors suggest a preferential metabolism 
of fatty acids (Hersey, 1977) whereas in dog gastric mucosa 
major increases in glycolytic intermediates were found without 
significant changes in the glycogen stores, which suggests' 
metabolism of glucose (Sachs, Chang et al, 1977). 
The differences in these results may reflect enhancement of more 
than one metabolic pathway, with variation in the pattern under 
different experimental conditions and in different species. 
The second major question is whether these metabolic events are 
a major primary effect of the gastric secretagogues: viz. the 
mobilisation of substrates (thus constituting a rate-limiting 
metabolic step) or whether these events are secondary to the 
increase in demand for energy. Increased energy utilization or 
uncouplers of oxidative phosphorylation such as dinitrophenol 
normally results in a shift of the respiratory-chain components 
to a more oxidized form (Hersey, 1974). In contrast, in vitro 
studies with amphibian gastric mucosa indicate a transition of 
these respiratory-chain components to a more reduced form 
following secretagogue administration (Hersey, 1974). These 
redox changes occur shortly after the onset of stimulation and 
before actual secretion of acid commences. These observations 
combined with the increase in oxygen consumption therefore are 
most consistent with a primary mobilisation of substrate by the 
secretagogues ( Hersey 1974, 1977). 
Two final related questions regard the source of the hydrogen 
ions for the secretion of acid and the means of delivery of 
metabolic energy to the hydrogen ion pump. Two theories have 
been proposed to deal with these questions. The first theory, the 
redox theory, suggest that hydrogen ions are directly generated 
from the oxidation-reduction process and delivered to the 
secretory surface via the electron transport system. 
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The second theory, for which evidence is increasing, the ATP 
hypothesis, proposes that ATP generated from substrate metabolism 
provides the necessary energy via a specialized membrane ATP-ase. 
5:J Membrane Events during Acid Secretion 
5:J:1 Morphological Transformation 
The parietal cell undergoes a very dramatic morphological trans-' 
formation with stimulation (Forte, Machen and Forte, 1977). 
In the resting state the cytoplasm of the parietal cell is filled 
with tubulovesicles, which is specialized smooth endoplasmic 
reticulum. With stimulation, these tubulovesicles coalesce to form 
extensive secretory canaliculi that are lined with microvilli and 
that communicate with the luminal surface of the cell. This 
transformation must involve the cytoskeleton of the cell, although 
the details of the role of microfilaments and microtubules in the 
transformation and in the equally complex reversion to the resting 
state remain unknown (Forte, Machen and Forte, 1977). Carlisle, 
Chew and Hersey (1978) showed that these changes in the parietal 
cell surface membranes appeared to be dependent on cyclic-AMP. 
The acid secretory apparatus is apparently housed in the membranes 
of the tubulovesicles and secretory canaliculi. The function of the 
morphological transformation that the parietal cell undergoes with 
stimulation seems to be to increase the luminal secretory surface. 
+ The H Pump 
ATP is an energy source in tissues throughout the body. It is 
formed mainly by phosphorylation of ADP, a reaction which is 
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tightly coupled to the energy production by the oxidation reactions 
in the mitochondrial respiratory cytochrome system (Lehninger, 1975). 
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When ATP is me tabolized in a rea c tion c atalysed by ATP-ase there 
is energy relea sed and the formatio~ of a proton plus ADP . 
Thus 
-? , -1 2 + ATP~+ H
2
0 ~ ADP + P + H 
There are several ATP-ase s present in gastric mu c os a . However, recently 
a specialized K+-stimulated ATP-a s e has been des c ribed which appears 
to represent a major component of the concentrating mechanism for 
the hydrogen ion (Forte and Lee, 1977). + This K -stimulated ATP-ase 
has b e en found i ~ abundanc e i n five spec ies thu s far. It is associated 
with the parietal c e ll s , and in development studies with tadpoles, 
the ap?earance of this enzyme coincides with the development of the 
tuhulovesicles and with the appearance of the ability to secrete 
acid. In recent years techniques have been develop e d fo r isolating 
the vesicles derived apparently fro~ the tubulove si c l e s of the 
parietal cell (Sachs, Chang e t al 1977, Forte and Lee, 1977). 
. K+ . These vesicles co~tain the -stimulated ATP-ase and when exogenous 
ATP is added, they are able to concentrate acid within them. Anti-
bodies made to highly enriched preparations of these vesicles react 
with the supranuclear region of the parietal cell and inhibit both 
hydrogen ion concentration by the vesicles and the K+-ATP-ase (Sachs, 
Chang et al, 1977). Studies with these vesicles indicated that the 
behaviour of the hydrogen-ion pump is best described by a model 
+ + of active H /K exchange, with a passive KCl link. (Sachs, Chanb 
et al, 1977). The function of these vesicles is not inhibited by 
Cl removal from the medium and therefore differs fro~ in vitro 
studies with intact mucosa where removal of serosal Cl markedly 
inhibited acid secretion (Durbin, 1977, Rehm and Sanders, 1977). 
Under conditions of Cl removal in the latter studies with intact 
mucosa, hydrogen ion secretion appears to be an electrogenic 
mechanism rather than a central exchange mechanism ~s · it appears 
to be in isolated vesicles. The acid secretory mechanism thus 
appears to be more complex than simply the K+-stimulated ATP-ase 
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in the apical membrane. Nonetheless this enzyme appears to be a major 
+ component of the H pump. 
CHAPTER 6 
CARBONIC ANHYDRASE - ITS ROLE IN THE 
PARIETAL CELL ---
6: 1: Introduction 
Th e Carbonic anhydrases (CA) are a group of enzymes that catalyse 
the reversible reaction: 
In the presen c e of suitable buffers the overall reaction is: 
OH + CO
2 \ ' (Maren, 1967) 
The funda~ental change that occurs is fro~ a no~-polar gas with a 
linear structure O = C = 0 to an acid or its conjugate bases with 





The enzyme has a wide distribution in n a ture. A CA is present in 
plants where it is thought to be in volved in photo3ynthesis (Burr, 
1935). Certain strains of bacteria Neisseria to~ have been found 
to possess a CA. These differ in structure fro~ ma mm a lian CA. 
(Veitch and Blankenship, 1963). Their functio~s however remain the 
same. Carbonic anhydrase is pres ~nt throughout the animal kingdom, 
both in invertebrates and vertebrates and develops earl y in the 
embryo's life. In the human, CA activity in the stomach can be 
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detected as 9arly as the fourth mo~th of gestation. (Berfenstam, 1952). 
In vertebrates the enzymes are found in associatio~ with ion 
transporting epithelia. Thus in mamnals CA activity is found 
mainly in the stomach, red blood cells, the renal cortex, the 
the eye and salivary gland3, with smaller amoun ts pres ent in the 
choroid plexus of the brain, the pancreas, the intestine, liver 
and the ute r us a n d lung. (Maren, 1967). 
In certain tissues such as the kidney s, the red blood cells and 
the stomach, the function of CA has been well studied. In other 
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tissues such as the brain and lung, its function is still conjectural. 
The enzyme differs from oth e r enzyme3 in gene ral in two respects: 
1) The reaction that it catalyses is inorganic. 
2) The reaction occurs at a significant rate without 
enzyme catalysis. 
Thus inhibition of CA does not prev en t the reac tion from occurring. 
at a The molecular mechanism by which CO2 is converted to HCOJ 
physiological pH is not known with certain t y. Kinetic data for the 




It is not pos~ible to say whether A or Bis catalysed by carbonic 
anhydrase although studies sugge3t that CA contains a binding site 
for HCOJ rather than H2 
co
3
• Enzyme bound OH- reacts with CO2 
and at a physiological pH the conversion may be directly; 
With a few exceptions, the work on the physical and chemical 
properties of CA derives from the red cells of various species. 
++ The red cell CA's are Zn containing proteins of J0,000 daltons 
with 1 mole of metal bound to one mole of protein. 
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They are relatively stable, water soluble and retain activity over a 
pH range of 6 - 10 with maximum activity at pH 8 and have isoelectric 
points varying fro~ 5.5 - 7.5, depending on the enzyme type. 
(Maren, 1967). ++ . t The enzyme loses its activity if the Zn mo1e y 
++ is removed and addition of Zn completely restores activity to 
the apoenzyme. ( Lindskog and Nyman, 1964). Certain other divalent 
ions can restore activity, notably cobalt. This factor may be 
important in the histochemical staining method for the enzyme. 
Cobalt, which is a molecular trap for the hydroxyl groups, produced 
by the action of the enzyme, will not inhibit the enzyme reaction, 
whereas other divalent cations such as copper and lead, would do so. 
In mammals, two major forms (isoenzymes) of CA exist. These have 
been called the high activity carbonic anhydrase (HACA) and the low 
activity carbonic anhydrase (LACA). In the guinea pig the HACA 
enzyme is 18 times as a c tive as the LACA. The ma mm a lian isoenzymes 
differ from one another in their amino-acid co~positions (the 
difference in serine co~tents being a consistent finding in a 
number of species) in their physical properties (isoelectric pH, 
retention by ion exchange resins, electrophoretic mobility) 
and their kinetic properties. (Maren, 1967). The CA's of the GIT 
are indistinguishable from those of the kidney and red blood cells 
although whereas both kinetic types of CA are found in blood, the 
stomach contains only the high activity form. 
6: 2 .Carbonic Anhydrase Localisation in the Stomach: 
Reports of the distribution of carbonic anhydrase in the stomach 
are conflicting. Biochemical measurements by Davenport (1939), 
indicated that in cats and rats the enzyme was predo~inantly in 
the parietal cells which has five to six times the carbonic 
anhydrase activity of red blood cells. The surface epithelial 
cells contained approximately o~e tenth the activity of the 
parietal cells. 
However, Boass and Wilson (1964), using an elaboration of the mano-
metric technique used by Davenport, indicated that in rats the 
highest enzyme levels were present in the muco~3-secreting columnar 
epithelial cells and that the oxyntic cells co~tained less than 
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25% of the activity of the surface cells. Studies of the distribution 
of CA by histochemical techniques have indicated that the enzyme 
is present in the surface epithelial and oxyntic cells, (Vollrath, 
1959), the oxynti c cell s only (Cross, 1970) and the oxynti c and 
chief cells (Winborn, Se elig and Girand, 1974). Th e se studies used 
a relatively less specifi c technique for the demons t r at ion of 
carbonic anhydrase. 
O'Brien, Rosen et al (1977) using a modification of Ha nsson's · 
method showed that in bullfrog gastric mucosa the entire fundal 
gland stains heavily for CA. This was confirmed by an isolated 
cell preparation of the frog's stomach, where biochemical estimations 
of CA in various cell fra c tions were all similar. Histochemical 
staining of rabbit and cat fundal mu c osa however, showed heavy 
staining in the parietal cells with no activity in the chief cells. 
There was also quite conspicuous staining in the neck and super-
ficial cells. The antral areas showed fairly marked staining 
throughout. Thus, it would appear that in mammals CA in the 
fundal area is limited to the surface and parietal cells. Lonnerholm, 
(1977), confirmed that in guinea pig the surface and parietal cells 
stained most heavily for CA. 
In terms of subcellular distribution, CA is predominantly a cyto-
plasmic enzyme. Narumi and Kanno (1973) prepared subcellular portions 
of gastric mucosa and found activity in the microsomal and mito-
chondrial portions. However, the greatest activity was in the cytosol 
fraction • 
. 6: 2 .: 1: Methods of Histochemical Localisation of Carbonic Anhydrase 
The first published technique for the demonstration of carbonic 
anhydrase (CA), was that of Kurata (1953). It has, however, been 
found to give unsatisfactory results by most workers (Hausler, 1958, 
Fand, Levine and Erwin 1959, Pearce, 1968). Hausler ( 1958), 
described a histochemical t ec hnique with sections floating on the 
reaction medium which was slightly modified by Waldeyer and Hausler 
(1959). This method is dependent on the dehydration of Hco3 by 
the enzyme thus: 
With the release of CO
2 
into the atmosphere, the OH- is trapped by 
co
++ 
in the medium and cobalt salts are precipitated in the areas of 
enzyme activity. The precipitated cobalt is then made visible as 
black CoS by dipping the sections into H2 S or (NH4 ) 2 s. The immediate 
precipitation of basic Co++ salts in the medium is prevented by 
adding so4 to the medium and by adjusting its pH to around 7.4. 
The drawback to this method was that the incubation times of 20 to 
120 minutes were so long that diffusion of the enzyme or the reaction 
product could take place. Furthermore, inhibition of the staining 
required the presence of acetazolamide, an inhibitor with a K1 of 
-8 about 10 M, in millimolar concentrations. 
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This made it doubtful th a t the staining which occurred was 
specifically catalysed by CA, and difficult to differentiate from 
the non-catalysed reaction which occurs simultaneously. The method 
was improved by Hansson in 196 7 and this method now seems to be 
generally accepted to be both specific and sensitive (Lonnerholm, 
1975). Hansson's basic ch a nge to the old method was the addition 
of phosphate to the medium. This changed the composition of the 
reaction product and allowe d much shorter incubation times i.e., 
1 to 15 minutes. 
A further more important difference was that the specific inhibitors 
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of CA at mi c romol a r conc e ntr a tions reduc ed the densit y of the staining. 
The composition of the new r e action produc t was beli e v e d to be a 
cobalt-phosphate complex. Hansson found that by alt e ring t he 
concentration of phosphate in the me dium the appearan c e of uncatalysea · 
staining could be delayed. Lonnerholm (1975) show e d t hat the stain-
ing reaction time correlated well wi t h 32P deposition in the 
sections, confirming the probable formation of this c obalt-
phosphate complex. 
In Hansson's method, sections are floated on the surface of a 
freshly prep a red incubation medium containing NaHco
3
,coso4 and KH 2Po4 • 
The dehydration of HCOJ to CO
2 
and OH- is still the b a sis of the 
staining reaction. Continuous local OH formation at sites of CA 
activity causes deposition of the basic cobalt phosphate complex 
(CPC). 





S ~ CoS (Black precipitate) 
The exact nature of the cobalt-phosphate complex is unknown. The 
release of CO
2 
from the rea c tions is rate-limiting. If there is no 
free flow of co
2 
off the sections or if the reaction is carried 
out in a CO
2 
environment, staining does not occur. For this reason 
Hansson suggested floating the sections on the surface of the 
reaction medium. Furthermore, he found that if the sections dipped 
below the surface of the medium, staining was inhibited. Hansson's 
technique has been criticised by Muther {1972), but Lightfoot and 
Cassidy (1973) and Rosen and Musser (1972) argued in favour of 
the validity of the method. Lonnerholm {1975) provided strong 
evidence in favour of the specificity of the technique. He showed 
that the staining was enzyme-dependent by allowing solutions of 
the 2 isoenzymes of carbonic anhydrase to infiltrate filter paper. 
Using the same histochemical staining technique he showed staining 
of the filter paper at the sites of infiltration. The activity of 
these isoenzymes was estimated by the highest dilution of the 
enzyme to cause visible staining of the filter paper. These measure-
ments correlated well with the relative activity of the enzymes 
as measured by biochemical methods. 
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Furthermore, Lonnerholm (1975) showed that staining of the filter 
Zn
++ paper did not occur with the free apoenzyme, but addition 
+++ . . of Zn restored activity - both in the staining reaction on 
filter paper and by biochemical estimations. Co++ added to the apo-
++ enzyme restored about 50% of activity by both criteria while Ca 
had no effect. 
Other studies in which Hannson's method has been used successfully 
include those of Hansson (1968), Laurent, Dunel and Barets (1969) 
Pesetsky (1969), Lauwers, Boedts and Geerinckx (1970), Rosen (1970, 
1972 a, b) Musser and Rosen (1973 a, b), Rosen and Friedly (1973), 
Battercherjee ( 1971, 1972), Lonnerholm 1971, 1972, 1973, 1974) and 
O'Brien, Ro sen et al (1977) and Lonnerholm (19 77). Distinct and 
consistent staining patt erns were reported by these authors. 
Furthermore, available biochemi ca l d ata was :found to correlate well 
with histochemical staining. 
Loveridge, Bloom et al (1974) and Loveridge, Hoile et al (1978) 
used a modification of this technique in the cytochemical assay 
for gastrin. In this technique the CA activity assessed in gastric 
parietal cells by measuring the density of the histochemical stain 
was found to relate directly to the concentrati on of gastrin used 
to treat the tissues. The histochemical staining of carbonic 
anhydrase in the parietal cells may therefore not only reflect 
localisation of the enzyme but quantitation of enzyme activity. 
This will be further discussed below. 
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~: The Function of Gastric Carbonic Anhydrase: 
When Davenport first showed in 1939 that carbonic anhydrase (CA) 
was present in the acid producing cells of the stomach, he 
suggested that the function might be to catalyse the hydration of 
CO
2 
furnishing hydrogen ions for secretion. However, in 1946 he 
reviewed the literature to that date and concluded that the 
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spontaneous rate of hydration of CO
2 
was just sufficient to account 
for the observed rates of acid secretion and that CA was not 
necessary for acid secretio~. He based this conclusion on three 
groups of experiments and on the r a te constant (K
1
) for the 
uncatalysed hydration of CO
2 
which h a d been cal c ulated by Roughton ' 
and Booth to be 0.13m/sec . (1946). Davenport therefore cal c ulated 
that the velocity of the uncatalysed rea ction would a cc ount 
entirely for the hydrogen ion production by the cat stomach. 
Secondly, Da venpo r t quoted the work of Feldberg, Keilen and Mann 
(1940) who showed that the CA inhibitor sulph anil a mide increased 
histamine- stimulated acid secretion rather th a n inhibiting it. 
This he confirmed himself in 1941. Unfortunately however, he did 
not distinguish between stimulated and basal acid secretion. 
Furthermore, sulphanilamide is a poor inhibitor of CA (Maren, 1963a). 
In 1948 Davenport and Jensen published the results of an experi-
ment utilizing the isolated mouse stomach as a model. They again 
showed no decrease in acid secretion after the CA inhibitor thio-
pentane-2-sulphonamide. In the light of current knowledge, 
Davenport's conclusions are now open to criticism. 
Firstly, the K
1 
for the uncatalysed hydration of CO
2 
at 37°c is 
now thought to be in the region of 0.4Jm/sec (Maren, 1963b). 
Maren (1967), recalculated Davenport's data on the basis of the 
corrected K1 
value and found that only approximately one third of 
the actual rate of acid secretion could be furnished by the un-
catalysed reaction. Secondly, Davenport does not distinguish 
between basal and stimulated acid secretion. In certain species 
basal acid secretion is low and the rate of acid secretion may 
well be totally accounted for by the uncatalysed reaction alone. 
A CA inhibitor in these anima~s might therefore be expected to have 
little or no effect. 
Feldberg, Keilen and Mann (1940) used histamine to stimulate acid 
secretion. However, the CA inhibitor was administered 1 - 2 hours 
before the histamine, during which time metabolic acidosis may 
have developed, secondary to the effect of the agent on the kidney. 
Byers, Jordan and Maren (1962), showed that metabolic acidosis 
itself caused an increase in acid secretion and that CA inhibitors 
may have a biphasic effect, firstly inhibiting and then enhancing 
acid secretion. This would have accounted for the increase in 
acid secretion noted by Feldberg et al. Davenport and Jensen's 
mouse stomach model was unusual in several respects, making the 
data difficult to interpret. Firstly, the rate of acid secretion 
achieved even after secretagogues was low. Secondly, histamine 
did not cause an increase in acid secretion although acetylcholine 
did. Under these circumstanc~s the viability of the model must 
be seriously questioned. The CA inhibitor had no effect but this 
may be related to the low rate of acid secretion which occurred. 
Davies and Roughton in 1948 disagreed with Davenport's position. 
Using a higher gastric secretion rate than Davenport but keeping 




was too slow to account for the physiological 
process of acid secretion. 
Janowitz, Colcher and Hollander (1952) showed that 20 mg/kg abeta-
zolamide reduced H+-ion concentration and output after histamine 
stimulation of dogs with vagally denervated (Heidenhain) pouches. 
Byers, Jordan and Maren (1962) showed essentially the same as 
Janowitz et al. However, they used 5 mg/kg acetazolamide and 
produced greater inhibition of acid secretion than Janowitz et al. 
This may again have been due to the acid-base changes and metabolic 
acidosis induced by the CA inhibitor in the higher doses. Powell, 
Robbins et al, (1962) using the intact dog stomach and maximum 
+ 
histamine stimulation, yielding acid secretory rates of 20 meqH /hr 
demonstrated a fall in acid secretion to about 4meqH+/hr after 60mg/ 
kg acetazolamide. Maren (1967) has calculated that in all three 
instances quoted above, the acid secretory rate recorded after full 
CA inhibition is in good agreement with the theoretical acid 
production which could be produced by the uncatalysed dehydration 
of CO
2
• In making this calculation he took into account the total 
parietal cell bulk (10 to 15% of total mucosa! cells) and the known 
K
1 
of this reaction at 37°c. 
Further evidence in this field was provided by Emas (1962) 
He found firstly that histamine-and gastrin-induced acid secretion 
was inhibited by acetazolamide to approximately the same degree 
in cats. Secondly, there was a smooth dose-response curve from 
10mg/kg acetazolamide (no effect) to 50 mg/kg (maximal) and thirdly; 
at low levels of H+ secretion (about 0.8 meq/hr) maximum drug 
effect reduced secretion about 50%. At high levels (about 2.6 meq/ 
hr), the drug reduced secretion about 80%. 
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The residual secretion aft e r complete inhibition was always 0.4 -
o.6 meq/hr. 
If the theoretical uncatalysed rate of CO
2 
dehydration is calculated 
for the cat, the production of H+-ions is very close to the acid 
secretion recorded, i.e., O.J2 meq/hr. Finally, Maren (1967) re-
ported that the rate of acid secretion during full carbonic anhydrase 
inhibition could not be in c reased by additional histamine. In man, 
inhibition of acid secretion by acetazolamide has been noted by 
Texter and Ba rborka (1955), Janowitz, Dreiling et al, (1957), 
Hirshowitz, London and Wiggins (1959) and Gailitis and Schreiber 
(1960). All of these authors made use of different doses of aceta-
zolamide, given by differe nt routes. As such, duration and extent 
of inhibition of a c id secretion vari e d with the different authors. 
Two g r oups, Mauro and Liffredo (1959), and Poller (1956), 
concluded that the slight d e gree of acid inhibition no t ed was not 
significant. The rate of induction of metabolic acidosis secondary 
to the drug, with its stimulant effect on acid secretion is the 
probable reason for such conflicting reports. The degree of 
metabolic acidosis would vary with the varied conditions described 
above. 
Thus there is now overwhelming evidence that acetazolamide, which 
is a CA inhibitor, inhibits acid sec retion. There is also good 
evidence that the acid secretion which occurs after total CA 
inhibition in approximately equal to the acid which would result 
from the uncatalysed hydration of CO
2
• Lastly, acid secretion 
cannot be further stimulated in the presence of CA inhibition. 
From the data discussed one could conclude that Davenport's 
original suggestion may be correct, viz. that the function of 
carbonic anhydrase may be to provide the hydrogen ions for secretion 
by catalysing the dehydration of CO
2
• Most or all of the hydrogen 
ions secreted in the basal state could be accounted for by the un-
catalysed reaction while high rates of acid secretion would require 
the reaction to be catalysed. 
The question of the origin of the hydrogen ion and acid secretion 
has been discussed previously. If the hydrogen ion originated 
directly from the dehydration of CO
2 
one would expect that inhibi-
tion of CA would lead to an immediate cessation of acid secretion. 
Hersey and High (1971), showed in frog gastric mucos a , that stimu-
lated acid secretion continued at the same rate for about 5 to 15 
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minutes after acetazolamide administration, before there was evidence 
of inhibition of secretion. However, following th e administration 
of diamox, there was an immediate rise in intracellular pH, which 
reached an apparently stable value in J to 5 minutes, and remained 
relatively stable for at least one hour. 
This alkaline shift in the cell would be consistent with the hypo-
thesis that carbonic anhydrase maintains the intracellular milieu 
by maintaining intracellular neutrality. (O'Brien, Rosen et al, 
1977). Thus for every hydrogen ion secreted, a hydrogen ion must 
replace it in the intracellular ionic pool. Secondly, every 
hydrogen ion secreted on the luminal surface of the cell is 
accompanied by the excretion of a bicarbonate ion on the serosal 
side. This accounts for the phenomenon of the alkaline tide 
associated with acid secretion. (Davenport, 1977). 
The bicarbonate ion is formed by the action of carbonic anhydrase 
and is secreted at the serosal surface of the cell in exchange 
for a chloride ion by a system of neutral exchange (Berglindh, 
1977). (Fig. 6:1). 
The chloride is then secreted at the luminal surface of the cell 
by a system of active transport (Berglindh, 1977). This oc c urs 
separately from the H+ ion secretion, but balances the latter. 
The proposed function of CA in rel ati on to acid secretion is 
represented by Fig. 6:1. 
Plasma 
















FIG. 6: 1 FU t CTION OF CARBONIC ANHYDRASE IN THE PARIETAL CELL 
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The carbonic anhydrase activity (dark arrows) cata lyses 
the formation of HCO; + H+ which have a role in the 
mainten a nce of intracellular pH homeostasis. 
CA is also present in high concentrations in the surface cells of 
the stomach (Lonnerholm, 1977, O'Brien, Rosen et al, 1977). 
Schiessel Matthews et al (1980) and Kivilaakso and Silen (1979) 
have proposed that the function of the surface cell CA is the 
neutralization of influxing luminal H+ and re-extrusion of the 
acid and CA is thus important in the maintenance of mucosal 
integrity. This proposal is still unproven and the relationship 
between surface cell and parietal cell CA is not known. 
The conclusions therefore are that CA is an enzyme pre sent .in the 
cytoplasm of the surface and parietal cells of fundic mu c osa. 
In the parietal cells, although CA is not direct ly res pon s ible for 
acid secretion i.e., it is not the proton donor , stimulated acid 
secretion cannot occur for long in the absence of active CA. 
Furthermore, the activity of CA in the parietal cell as d e termined 




should balance the rate of hydrogen ion secretion in the 
stimulated state and thu s may be reg a rded as an index of stimulated 
acid secretion. This led to this work whereby CA activity, 
measured by quantitative cytochemistry was used to investigate acid 
secreta~ogue status and functions. 
CHAPTER 7 
THE MEASUREMENT OF THE GASTRINS AND THE 
CYTOCHEMICAL BIOASSAYS 
7: 1: Introduction: 
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The scientific method is concerned firstly with the formulation of 
a theory and secondly with the proof of the theory b y observation. 
Endocrinology in the broader sense deals with the fun c tion of 
biologically active subst a n c es (hormones) in many tissue s of the 
body. In order to observe the effects of perturbations of these 
hormones, one requires methods of assay which a re sufficiently 
sensitive, accurate, reproducible and sp e cific in ord e r to make a 
correct observ a tion. 
7:2: Mea s urements of Gastrin: 
The me a sure ment of g a strin, as with ma ny other hormones, started 
with a bioa ss a y. In the case of gastrin the r e sponse in gastric 
acid secretion evoked by administration of a test subs tance to an 
experimental a nimal was compared with that p r oduced by a standard 
reference preparation of known biological activity. Animals used 
in bioassay techniques which were described, included the cat, rat 
and dog, either in the anaesthetized or conscious state, Histamine was 
used as th e reference standard before preparations of gastrin 
were avail a ble, but there is considerable disadvant a ge in using 
a reference standard which differs from the test substan c e. More 
recently, pure or synth e tic hum a n gas trin h a s been us e d. 
For a reli a ble bioassay certain basic requirements must be met: 
The animal must be sensitive to gastrin; it must respond 
predictably to different doses of the test substance; the reference 
standard must be of a constant potency and it must behave as 
gastrin (Emas and Uvnas, 1973). 
The first method of gastrin bioassay that fulfilled these re-
quirements was described by Uvnas and Emas (1961) in cats with 
gastric fistulae. They too initially used histamine as the 
standard reference preparation, but subsequently showed that the 
sensitivity of the assay was 0.08-0.2 µg synthetic human gastrin 
(Emas and Uvnas, 1973). Other bioassays described included those 
of Blair, Harper and Reed (1962), later refined by Blair, Keelyside 
et al (1968), also in the cat, and Ghosh and Schild (1958) and 
Lai (1964) who used anaesthetized rat models. An improved bioassay 
for gastrin using the perfused rat stomach was described by 
Smith, Lawrence, et al (1970). This assay had a sensitivity of 
10 - 20 ng of synthetic human gastrin and th~ steepest part of 
the dose-response curve lay between 40 and 200 ng of synthetic 
gastrin. This assay was used to measure gastrin activity in the 
plasma and tumour extracts of a patient with the Zollinger-Ellison 
syndrome. 
It is apparent that until now the techniques of bioassay have 
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posed many limitations. Only a very small number of unknown or test 
specimens and in some cases only one, could be assayed at a time. 
Most methods are tedious and time-consuming to execute. Variations 
in the methods and animals used mad e comparison between different 
assays difficult. However, the greatest limitation was probably 
the insensitivity of these methods ~ith the lowest detectable level 
in the range of 1 ng (Walsh and Grossman, 1975). This is not 
sensitive enough to measure normal circulating gastrin levels, 
which are normally less than 100 pg / ml. Bioassay techniques were 
thus until recently thought to be useful only in the measurement 
of serum gastrin levels in hypergastrinaemic patients (Walsh and 
Grossman 1975). 
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However, bioassays can be performed with good precision, so that 
interassay variations are often less than 10o/o (Walsh and Grossman, 
1975, Loraine and Bell, 1971). A difficulty with gastrin bio-
assays is that they all measure acid secretion by one or other 
method. However, as has been extensively reviewed, acid 
secretion is the net effect of several stimuli acting together on 
the parietal cell. Thus it is difficult to measure th e gastrin-like 
activity present in biological fluids as these may contain a 
variety of other acid secretagogues. Thus these assays cannot be 
said to be specific for gastrin, except when they are used to 
measure the biological activity of purified gastrin extracts. 
Once pure gastrin preparations became availabl e , the technique 
of radioimmunoassay of gastrin could be developed (Y a low and 
Berson 1970a, McGuigan and Trudeau, 1970a). This t echnique is 
about a thousand times more sensitive than the old bioassays, 
allowing detection of gastrin levels as low as 1 picogram (Walsh 
and Grossm an, 1975) and large numb ers of serum gastrin estimations 
can be performed simultaneously with high sensitivity and 
relative specificity (Lora ine and Bell 1971, Walsh and Grossman 
1975). However it soon became obv ious that radioimmunoassay 
not only of gastrin, but of several other peptides too, had 
serious limitations. It was found that heterogenous forms of 
many peptides with different molecu lar weights and biological 
activity occurred (Yalow and Berson, 1970, 1971 , Rehfeld, Stadil 
and Vikelsoe, 1974). These include degradation produ c ts, 
prohormone forms, many of which are biologically inactive as 
well as various related biologicall y active molecules. Measure-
ments of these hormones therefore often depend upon the relative 
specificity of the antis erum for the different forms. 
In addition, protein interference in the assays gave rise to 
entities such as "big-big gastrin" (Yalow and Berson, 1972), 
• 
which have subsequently been shown to be artifactual (Rehfeld, 
Schwartz and Stadil, 1977). The result of this problem of anti-
genie variability is that· the immunoreactive measurements do not 
necessarily reflect biological activity and thus physiological 
function. 
Thus as long ago as 1967, a speci a l meeting convened by the World 
Health Organization recomm en ded the development of "Biological 
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microass ays " that would have the sam e s ensitivity as the equivalent 
radioimmunoassays and should be run in parall e l with th e m. In 
1974, Chayen and his colleagues described a group of cyto c hemical 
bioassays which were in many cases more than 1000 tim e s sensitive 
then immunoassays. Thus, although these assays lik e other bio-
assays, were tedious and time-consuming in their execut ion. for 
the first time biological activity of hormones in serum could be 
measured and compared to radioimmunoassay me as ur e me nts. 
7:J The Cytochemical Bioassays: 
These assays first described by Ch ayen and colleagues (Chayen, 
Daly et al 1976) revert conceptually to the functional analysis: 
since a hormone shows its ac tivity by causing a specific bio-
chemical effect in its target cell, it should be possible to 
measure the biological activity of a hormone by measuring a 
specific bioc hemical response in the target cells . 
This has been done in assays using dispersed cells (Sayers, 
Swallow and Giordano, 1971, Van Damme, Robertson and Diczfalusy) 
but for various reasons, including the tissue dilution artifact 
(Chayen, Jones et al, 1961), the difficulty in achieving a 
sufficient bulk of cells, and the damage to cells during the 
separation process, Chayen's group believed it preferable to be 
able to study the response of the target cells in their fully 
differentiated state, held in their natural stroma in their natural 
state. This was done by the cytochemical demonstration of a bio-
chemical reaction within the cells . . Quantitation of the reaction 
73 
was made possible by the development of the scanning and integrating· 
microdensitometer designed by Deeley (1955), that allowed the 
precise measurement of reaction products within cells even though 
the products were distributed inhomogeneously. 
Using this t echni que assays were established for ACTH (Daly, 
Loveridge et al, 1974; LH (Rees, Holdaway et al, 197J; TSH (Bitensky, 
Alaghband-Zadeh and Chayen, 1974;) gastrin (Loveridge, Bloom et al 
1974) and PTH (Chambers, Dunham et al, 1978 and Fenton, Somers and 
Heath, 1978). All assays were initially done on segments of guinea 
pig tissue but it became obvious that the procedure could be stream-
lined by using unfixed frozen sections of tissue without loss of 
sensitivity (Alaghband-Zadeh, Daly et al 1974; Loveridge, Hoile 
et al, 1978; Gilbert, Besser et al, 1977 and Buckingham, Chayen 
et a 1 , 19 79 ) • All the assays were several hundred-fold more 
sensitive than their respective immunoassays and serum had to be 
diluted 1:100 and 1:1000 for measurement in the assays. 
Thus for the first time gastrin-like biological activity in 
serum could be measured parallel to the immunologi c al activity. 
However, although Loveridge, Hoile et al (1978) claimed that 
histamine did not alter carbonic anhydrase activity, it was found 
as will be discussed, that both histamine and carbamylcholine 
caused dose-dependent increases in CA activity. Thus like other 
bioassays, this assay could not be said to be a specific gastrin 
bioassay but r a ther responded to total CA stimulatory activity 
(CASA) of serum. 
This work des c ribes the e s tablishment of the technique for the 
measurement of CASA in plasma by quantitative cytoc h e mist r y and 
shows how thi s technique may be modified to act as a model to 
investigat e a c id secretagogue interactions and their possible 
role in acid secretion. 
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ORIGINAL WORK SECTION B. 
QUANTITATIO~ OF CARBO~IC ANHYDRASE ACTIVITY IN 
PARIETAL CELL SECTIONS 
CHAPTER 8 MATERIALS AND METHODS 
8:1 Chemicals: 
Hepes (N-2-Hydroxyethylpiperazine-N~2-ethanesulphonic acid) 
(Sigma Chemical Co., St. Louis M.O., U.S.A.) 
Cobalt Sulphate (Analar grade, B.D.H. Chemicals, Poole, England). 
Sodium hydrogen carbonate (Analar grade, B.D.H. Chemicals) . 
. Potassium dihydrogen phosphate (Analar grade, B.D.H. Chemicals). 
Sulphuric acid (Analar grade, B.D.H. Chemicals). 
Gum tragacanth (Sigma Chemical Co.) 
Farrants medium (Searle Diagnostic, High Wycombe, England). 
Absolute Alcohol (Alchemist brand, Heynes Math ew, Cape Town). 
n-Hexane (Merck, Darmstadt, Germany.) 
Iron Sulphide (Merck). 
Toluidine blue (Searle Diagnostic). 
Synthetic Human gastrin (SHG-17-I) (Produced by I.C.I. London, 
England and distributed with CEA/Sorin gastrin radio-
immunoassay kits.) 
Histamine dihydrochloride (Merck). 
Carbamylcholine chloride (Merck). 
Acetazolamide (Lederle Laboratories). 
Atropine (Merck). 
Cimetidine (Smith, Kline & French Laboratories, Herts. U.K.) 
Hepes buffer was made up by titrating Hepes to the required pH 
with a concentrated solution of potassium hydroxide 
solution. 
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8:2 Laboratory Equipment: 
The dispensing apparatus was built by the Department of Bio-
engineering, Groote Schuur Hospital, according to specifications 
provided by us. A diagram of the apparatus is shown in Fig. 8.1. 
A Kipps apparatus was used to generate hydrogen sulphide. Iron 
sulphide granules were allowed to react with 50% concentrated 
hydrochloric acid. The Kipps apparatus was kept in a laboratory 
fume cupboard. 
A Slee cryostat (Vickers Ltd., Vick e rs Instruments, Croyden, 
England) was used to cut the frozen sections. The s c anning and 
integrating microdensitometer (M85) was supplied by Vickers Ltd., 
Vickers Instruments, York, U.K. 
Female Duncan Hartley outbred (DHP) guinea-pigs, weighing 400-
500 gms. were supplied by the Anim a l Unit, University of Cape 
Town Medical School. 
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Methods: 
8: 3: 1: Removal of the Stomach: 
A 450 - 500 gram female DHP guinea-pig was starved for 12 hours 
and then asphyxiated in nitrogen. The peritoneal cavity was 
immediately opened and the stomach excised, and rinsed in 0.025M 
Hepes buffer pH 7.0. A strip of fundus (about J - 4mm wide) was 
cut circumferentially from a constant portion just below the 
oesophago-gastric junction. This was rinsed in fresh buffer and 
undigested pieces of food particles were removed by gentle 
brushing with a fine camel hair paintbrush. The strip of fundus 
was then cut into cubes which were rinsed again in fresh buffer. 
8. J. 2: The Freezing Procedure: 
Crushed solid co
2 
was added to a chilling bath filled with 
absolute alcohol until a saturated solution was obtained. This 
state became obvious when, (a) the alcohol CO
2 
mixture became 
viscous; (b) ths addition of more solid CO
2 
did not cause 
bubbling and (c) the thermometer recorded about -70°C. A pyrex 
beaker, containing JO - 50 mls. of n-Hexane was put into the bath 
and covered with a glass lid. More solid CO2 was added to the 
bath to maintain the temperature. The Hexane was allowed to 
·o 
cool to about -65 C, when it was ready for use. 
The cubes of tissue were then dropped individually into the 
cooled hexane. Care was taken to ensure that the tissue was 
plunged straight into the hexane, without touching the sides of 
the beaker. 
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The specimen was left in the hexane for 1 minute and then trans-
o ferred by pre-cooled forceps to a dry tube, pre-cooled to -70 C. 
The tube was corked and stored, encased in dry ice in a Dewar 
flask. All specimens were used within 60 hours of freezing. 
8: J: J: Mounting the Tissue: 
During this procedure, care had to be taken to prevent the tissue 
from being warmed at any stage. All handling of the tissue was 
thus done with pre-cooled forceps. A piece of tissue was removed 
from the tube and placed in a cavity in a piece of co
2 
ice so 
that its orientation could be determined. To keep it at the 






bath was prepared at about -70 C. 
The metal chuck from th e cryostat was placed in this bath with 
the tip clear of the alcohol and left to equilibrate temperatures 
with the bath. A drop of water was then placed onto the chuck. 
This froze rapidly until only a thin film of water of comparable 
size to that of the specimen remained. The tissue was then trans-
ferred to this film of water and orientated to lie ·in a transverse 
plane. As the water continued to freeze, the specimen was held 
fast in the ice. The chuck was then transferred to the cryostat 
chamber where it was stored until use. 
8: 3: 4: Cutting the Sections: ----
Sections were cut in the cryostat chamber. The chamber was set 
at an ambient temperature of -20°c while the knife was cooled to 
-70°C by packing the hasp with CO
2 
ice. Sections 18 µm thick were 
cut and were lifted from the knife by carefully bringing a glass 
microscope slide at laboratory temperature, up to and parallel to 
the section on the knife. 
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The temperature gradient between the knife and the slide causes 
the sections to "jump" off the knife onto the slides. The central 
position of the sections on the slides was ensured by using a 
prepared transparent template, which fitted over the reverse 
surface of each slide. The slides were then stored in the 
cryostat chamber for up to 8 hours until use. 
8: 3: 5: The Reaction 
8: 3: 5: 1: Preparation of Standard Reference Solutions: 
The standard reference solutions were made up by diluting the 
test substance in 0.025M Hepes buffer pH 7.0 to the final concen-
trations desired. Each dilution of test substance was reacted 
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in triplicate in each experiment, with a total of 24 sections being 
stained during the course of each assay. 
8: 3: 5: 2: The Secretagogue Reactio~: 
The microscope slides were removed from the cryostat chamber, 
labelled, laid flat in the staining trough and allowed to dry for 
10 minutes. The syringes of the dispensing apparatus were filled 
with 200 V1 of the test substances. When the dispensing apparatus 
was placed in position over the staining trough, each syringe was 
orientated directly above a single section. The syringes were 
then emptied directly and simultaneously onto the sections. The 
reaction was allowed to proceed for 90 seconds before being 
stopped by the addition of the staining reagents. 
8: J: 5: J: Preparation of the Staining Reagents: 
Two solutions were made up from stock solutions and were added 
together just prior to use. 
Solution A consisted of 750mg NaHco
3 
in 40 mls. of 0.1M Hepes 
buffer, pH 7.4 + 0.001% gum tragacanth. 
Solution B consisted of 6 mls of 0.1M Coso
4 
6 mls 
4 mls distilled water 
1 ml 
This was added together to give a final solution consisting of: 
1.05 X 10-
2 M Co S04 
5.3 X 10-
2' M H2 so4 
15.7 X 10-
2 M Na Hco
3 
1.17 X 10- 3 M KH 2 
po · 
4 in the Hep e s buffer with 
a . final volume of 57ml. 
The mixture was very effervescent and prior to use was de-bubbled 
for a few seconds on the vacuum attachment of a laboratory tap. 
8: 3: 5: 4: The Staining Reaction: 
At the end of the 90 second secretagogue treatment, the staining 
reaction mixture was poured carefully over the slides. The 
staining trough was agitated gently, to ensure the even spread of 
the reaction mixture. The volume of the reaction mixture was 
such that only a thin film of liquid covered the sections. The 
80 
reaction was allowed to proceed for 2 minutes at room temperature, 
when the slides were washed twice in cold water. The slides were 
then placed in a solution of H
2
S in water for 90 seconds. 
This resulted in the formation of a dark brown precipitate of 
cobalt sulphide, which was visible in the sections. The slides 
were again washed in cold water and the sections were mounted 
in Farrants medium. Fig. 8.2 summarizes the method used. 
8: 3: 7: Quantitation of the Reaction: 
The sections were read on the Vickers M85 integrating and 
scanning microdensitometer. This is basically a spectrophoto-
meter which works through a microscope. The tissue is inspected 
with normal white light, and the cell to be read is selected. 
The rest of the section is then cut off by means of a stop. 
A monochromatic system allows the cells to be illuminated with 
light which is absorbed maximally by the histochemical reaction 
produ~t and this image is projected onto a photo-multiplier. To 
overcome the variation of stain which occurs within the cell, the 
image is transmitted point by point by means of an automatic 
scanning system. Each point in the selected image is measured 
separately and all readings of the selected field are integrated 
by the machine which registers the integrated absorption present 
in that field. The machine readings could then be converted to 
absolute units of extinction by measuring the absorption produced 
by a neutral density filter with a known density of 1. 
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In the case of the parietal cells, readings were taken at a 
wavelength of 550 nm and a spot size of 1. Parietal cells selected 
for readings were those which presented a full profile. These 
completely filled the A2 mask on the densitometer, which has a 
measured field diameter of 20mm when the 20 x objective lens is 
used. 
Approximately 15 to 20 cells per section were selected for 
readings. Particular care was taken that the cells were in a 
uniformly stained area of the section, that the section was not 
folded or frayed, and that the cell borders did not overlap 
adjacent cells, as this would give spuriously elevated readings. 
To eliminate the effects of non-specific attachment of cobalt to 
tissues and optical errors due to light scattering, the same 
number of measurements were made in the muscularis mucosae of 
each section. The mean of the muscle measurements were subtracted 
from the me an of the cell measurements for each section. To correct 
for instrument variation, the instrument was calibra ted by taking 
readings of the stand a rd filter with an ' optical d e nsity of 1 prior 
to, and after taking the readings in each section. Th e se measure-
ments were used to calculate the mean integrated extinction, (MIE), 
which for convenience, was multiplied by a hundred. 
MIE = (Mean reading of cells - mean reading of muscle)~ 100 
D1 
where D1 is the reading of the standard d&nsity filter, 
optical density of 1 . 
Standard dose response curves were constructed relating the 
percentage integrated extinction to the log secretagogue dose. 
e 
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For the purposes of the cytochemical bioassay for carbonic anhydrase 
stimulating activity (CASA) of serum, SHG-17-I was used as the 
standard reference preparation. The MIE x 100 of the diluted 
unknown sera was similarly plotted on a semi-log scale and the 
CASA determined by extrapolation from the standard dose response 
curve or substitution in the equation of the straight line 
relationship between extinction and the log gastrin dose. 
FIG.8:1 Dispensing App a ratus for Cytochemical Staining 
The entire instrument was constructed from perspex. The staining 
trough (33 x 17cm) contained 24 microscope slides (D), held in 
place by th e crossbeam (C). The upper part of the apparatus 
containing the 1 ml. disposable syringes (B) was detac hable from 
the staining trough below. The syringes were held by the base-
plate (E) and the plung er plate. The plunger plate was kept 
steady with the guide screws (A) and allowed all the ·syringes to 
be filled and emptied simultaneously. 
83 
Fasting guinea pig asphyxiated in nitrogen 
Stomach removed and washed in Hepes buffer 
0-25M pH 7.0 ... 
Strip removed from fundus 
containing parietal cells 
~ 
Segments frozen in n-hexane - 70° C 
Segments mounted in ice 
on cryostat chuck 
1~ sections cut on cryostat 
200 µI Test substance added for 
90 seconds 
Cytochemical staining for carbonic 
anhydrase activity 
FI~ . 8:2 Summary of Method for Cyto chemica l Staining 
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8:4: Results: 
Fig. 8:J and 8:4 shows the fundic mucosa stained for carbonic 
anhydrase activity by the method outlined. The cytoplasm of 
the parietal cells are stained dark brown by the cobalt 
sulphide precipitate. The nucleus of the cell remains pale. 
-16 -10 A dose response curve of gastrin 2.5 x 10 to 2.5 x 10 
mol/1 is showm in Fig. 8:5. The response is linear from 
-15 -12 2.5 x 10 to 2.5 x 10 mol/1. 
The readings taken from a typical gastrin dose response curve 
are shown in Table 8:1. The coefficient of variation of the 
density measurements between cells of a given sec tion ranged 
from 2.2 to 6.9% while the variation in the muscle me asurements 
~anged from J.7 to 10.J o/o . Thus in order to reduce th e error 
between 10 and 15 cells and muscle fields were measured on 
each section. This reduces the percentage error to between 0.7 
and J.2%. 
The coefficient of variation of readings taken by the instrument 
on a single cell was measured on several occasions .and was 
always found to be less than lo/o. This variation wa s sufficiently 
low for a single reading on each cell or muscle field to be 
acceptable. 
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FIG 8:J Guinea pig fundic mucosa stained for carbonic anhydrase 
activity. The cobalt sulphide precipitate stains 
darkly in the cytoplasm of the parietal cells, leaving 
the nucleus pale. 
M Muscularis mucosa 




FIG. 8:~ Low power view of guinea pig fundic mucosa 
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§...:..5 Discussion: 
The cytochemical section bioassay for gastrin (Loveridge, Bloom 
et al, 1974), whose method has been modified here, entailed pre-
incubation of segments of gastric fundic mucosa in maintenance 
culture for 4 to 5 hours prior to their treatment with gastrin. 
The tissue was then treated with gastrin, snap-froze n and stained 
for carbonic anhydrase (CA) activity. When their method was 
modified to the section bioassay (Hoile and Loveridge, 1976), this 
pre-incubation stage was excluded. However these workers found that 
the basal CA activity tended to vary between animals a nd suggested 
that this may have been due to differences in the b asa l background 
gastrin level of the animal (Loveridge, Hoile, et al 19 78). They 
therefore re-introduced the pre-incubation of the s e gm e nts in 
Trowell's T8 medium, followed by the pre-treatment of s e gm ents 
with a sub-threshold dose of gastrin (Loveridg e , 1978). These 
segments are then frozen, sections cut and treated with gastrin 
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in much the same method as outlined above. Loveridg e , Hoile et al 
(1978) stated that this pre-incubation step dec reased and standardised 
the blank activity without altering the sensitivity of the response. 
An attempt was made to confirm thes e findings in this study. The 
author found that the probl e ms associated with the pre-incubation 
of tissue did not warra nt the addition of this step. Th e se problems 
included: 
1) Bacterial c ontamination of the incubation medium which was 
unavoid able without added antibiotics. 
2) pH changes in the Trowell's medium due to gas leaks and 
possible acid secretion b~ the segments. 
Although it may be true that the pre-incubation phase may reduce 
the background gastrin effect, many of the amino-acids in 
Trowell's medium are potent stimulators of acid secretion them-
selves, some independent and others dependent on histamine 
(Konturek, Tasler et al, 1977). There is thus no reason why the 
pre-incubation phase may not produc e its own background effect. 
The author found that in practice, unstimulated sections gave 
very constant readings of background carbonic anhydrase activity . 
The coefficient of varia~ion for these readings was J.2% which 
was highly acceptable. This low variability appeared to depend 
on two factors: firstly the animal had to be starved for a 
minimum of 12 hours prior to sacrific e and secondl y, the time 
from sacrific e to freezing of the tissue had to b e k e pt to a 
minimum with as little trauma to the tissues as possible. Further-
more, the omission of the preincubation phase allowed up to four 
staining 'runs' to be done per day, whereas the preincubation 
phase limited this to one or possibly two per day. _ It was thus 
felt that the disadvantages of the preincubation phase outweighed 
the advantages and this step was omitted. 
The reason for freezing the tissue segments in hexane rathe~ than 
in liquid nitrogen is discussed by Chayen, Bitensky and Butcher 
(1973). The rate of cooling of the tissue in hexane is twice as 
fast as when chilling in liquid nitrogen. As such, fewer 
temperature gradients are set up within the tissue and ice 
formation, which may distort or damag e the tissue, does not occur. 
This has been shown by Lynch, Bitensky and Chaye n (1966 ), using 
a thermocouple in the tissue; by Silcox, Poulter et al (1965) 
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following microscopic examination for the ice crystals or damage 
produced by them; using dark ground illumination to investigate 
denaturation-aggregation of the protoplasma and lipid protein 
associations (Chayen, 1968a); or studies of the permeability of 
subcellular membranes (Chayen, 1968b). 
Mounting of the tissue before sectioning was done in ice, as the 
use of synthetic mounting materials prevented the secretagogue 
reaction from occurring. This possibly occurred by interfering 
with the receptor-binding sites on the cells. 
The sections were cut in the cryostat to a thickness of 18 ll m. 
This thickness was chosen so as to contain not more than one 
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parietal cell. A parietal .cell varies in diamet er from 12 to 17 µm . 
(Davenport, 1977). In addition Loveridge (1978), showed that the 
extinction increased linearly with thickness over the range 10 
to 22 µm. 
The removal of the sections from the cryostat knife is the method 
described by Chayen, Bitensky and Butcher (1973). Using this 
method the section moves across a temperature gradient from the 
knife (-70°c) to the slides (room temperature). There is no need 
to press the slides against the section and the section remains 
frozen in the low ambient temperature of the cryostat chamber 
(-20°c.) and can be stored there until use. 
The pH of the buffer in which the gastrin was diluted was 7.0. 
Loveridge, Bloom et al, (1974) found an increased basal level of 
CA activity when the segments were maintained at a higher pH. 
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This was confirmed by the author (Fig. 8:6), although differences 
noted at higher pH were far less than those reported by Loveridge, 
Bloom et al (1974). Thus it appeared that the pH 7.0 gave the 
lowest and most consistent basal staining. 
Initially there were two major problems encountered during the 
development of the staining method. 
(a) Staining was faint and non-specific. 
(b) The sections washed off the slides and were lost 
during the staining procedure. 
(a): For some time during the early developme nt of th e method it 
was found that the sections stained lightly and that th e staining 
was non-specific. In many cases the muscle layer stained darker 
than the mucosa. Lonnerholm (1975) found in staining for CA that 
the tissue had to float on top of the reaction medium. This 
appeared to be critical as sections which dipped below the surface 
of the medium remained unstained. He proposed that the presence 
of staining reagent above the section prevented the free loss of 
CO
2 
which is a rate-limiting factor in this reaction. As it was 
impossible with the cytochemical bioassay to float th e sections 
on the reaction medium it was dec id e d to reduce the volume of the 
reaction m~dium so that the tissues would be covered by a film of 
liquid of approximately 1mm in depth. Using this method specific 
staining was obtained. Thus the total volume of 57mls of staining 
reagent was critical for the staining trough that ~as used. 
This finding was subsequently confirmed by Loveridge (1978), who 
showed decreased staining with increased depth of reaction medium. 
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(b): The second major problem was that the sections did not stick 
to the slides and were washed off during the staining procedure.' 
It was noticed that during the staining reaction small bubbles 
appeared on the sections in the effe rv e scent medium. It was 
suggested that these bubbl e s of eff e rv e scence may have had the 
effect of lifting the sec tions off t h e slides. De-bubbling the 
r e a c tion me dium by vacuum pump for a few seconds prior to use 
a ppeared to solve this probl e m. 
The reaction medium was modified by Loveridge (1978) from that of 
Hansson (1967) and Lonnerholm (1975 ) . Both these latt e r workers 
used a non-buffered reaction me dium. Howev e r t h e evolu t ion of 
CO
2 
in the reaction medium (du e to t h e reac tion b e twe e n sulphuric 
ac id and bicarbon a t e ) c a us e s a chang e in pH in th e me dium. 
Love r idg e (1978) found that the pH ro s e r apidly to ov e r 8 over the 
first two minutes after mixing solutions A and B. In an attempt 
to slow this excessive c h a ng e in pH, the reaction me dium was 
buffered by Hepes pH 7.4. This was chosen becaus e it had been 
shown tha t it did not affect the bioc hemical characteristics of 
two of the carbonic anhydrase isoenzy mes (Christiansen and Magid, 
1970). Loveridge showed that the buffered reaction me dium 
markedly slowed the pH chang e and th e pH remained b e tween 7.0 ' 
and 7.4 for the duration of t h e s ta ining run. 
Lov e ridge (1978) d e monstrat e d a lin ea r CA reaction for up to 
4 to 6 minutes. Shortening the reac tion time to two minut e s mini-
mized the time related pH change in th e medium but allowed 
sufficient dis c rimination b e tween l e vels of enzyme activity at 
each gastrin conc entra tion. Other modifi c ations to the constituents 
of the reaction medium proposed by (~overidge (1978) and followed 
by the author, included the use of phosphate at concentration 
1.2 mmol/1, which appeared to aid in the activation of the 
enzymes. 
Phosphates at higher concentrations caused an increased non-
specific staining, possibly due to a decrease in the solubility 
of the reaction product. In addition, the concentration of 
cobalt in the medium was increased to 10mmol/l, as when the 
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buffer was included in the reaction medium there was competition 
with the cobalt for the hydroxyl ions. Furthermore, gum tragacanth 
was included in solution Bas it was found to retard the precipita-
tion of uncatalysed reaction products. (Loveridge, 1978). 
For several cytochemical staining techniques the solubility of 
the enzyme makes it obligatory for a colloid stabilizer such as 
polyvinyl alcohol or a collagen preparation des{gnated polypeptide 
5115 to be used in the reaction medium (Chayen, Daly et al, 1976). 
Loveridge has shown that CA is tissue-bound under the conditions 
of the assay and thus the reaction medium does not require these 
additives. This is in spite of the report by Narumi and Kanno 
(1973), who showed that CA activity occurred mainly in the cytosol 
fractions of gastric mucosal homogenates. 
The density of the staining was quantitated by the Vickers micro-
densitometer. As the density of stain is an indication of 
reaction products and as the reaction was in each case allowed to 
proceed under similar conditions of temperature, time and pH, the 
density of the stain reflected CA activity. 
While it is beyond the scope of this work to discuss the theory 
of microdensitometry, the microdensitometer is basicall y an 
instrument in which a microscopicall y enlarged imag e of a cell 
is scanned by a slit and th e light from th e slit is passed 
sequentially on to a photomultiplier. Th e size of the slit is 
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sufficiently small that no optical inhomogen e ity occurs within it; 
the photomultipli e r is th e reby confront e d with a la r ge number of 
single optically homogen e ous fields, and the r e sponses for each slit 
field are integrated to give the mean integrated extinc tion. This 
makes it possible to me a sure precisel y the density of r eaction 
p r oducts within the cells, even though th e produ c t is not distributed 
homogeneously. The scanning and int e gration occurs within about 
5 seconds. The wavelength of 550nM was u s ed fo r r eadi ng s , as at 
this wavelength th e re was ma ximal dis c rimination be t ween the cells 
and the background readings. Thi s is shown in Fig. 8:7 where the 
r e adings of a single cell and mus c le f i e l d a re plott e d at varying 
wavelengths. This wave leng t h was us e d for all studi e s. 
>. 
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FIG. 8: 7: Readings at varying wavelengths of a single cell 
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(open circles) and a single muscle field (squares) stained for 
C.A. activity. The cell/muscle difference (triangles), is maximal 
at about 550mm. The closed circles designate readings taken of 
the standard filter. 
8:6: Validation of the Reaction: 
Having described the method, certain of the technical problems 
associated with development and the steps taken to ensure 
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optimum conditions for the technique, we now turn to the validation 
of the technique. As has been mentioned, the mean integrated 
extinction is being regarded as an index of CA activity. The 
question arises whether this is in fact so. Perhaps the best 
method of answering this question may have been to establish a 
parallel system to measure CA by an alterriative chemical method. 
Unfortunately this was not possible without altering the basic 
model to such an extent that the two methods would no longer be 
considered strictly comparable. Therefore, for the purposes of 
v a lidating the enzyme reaction, the tissue was boiled to d e nature 
the enzyme and the specific CA inhibitor, a c etazolamide, was used. 
Lastly, as acid secretion is inhibited by anoxia (Hersey and High, 
1972), the effect of anoxia on CA activation was e xamin e d.' 
8:6:1: Enzyme Denaturation: 
In the first study, sections of fundus were placed in boiling 
water for 5 minutes. This will denature most large proteins and 
enzyme activity is usually destroyed by this procedure . The segments 
were then snap-frozen, sectioned and treated with gastrin in the 
usual way. The results are shown in Fig. 8.8. After boiling the 
tissue, gastrin no longer caused an increase in the int e grated 
extinction. It is of note that staining of the tissue still 
occurred with a basal mean integrated extinction x 100 of 
12.5. Thus, in spite of the absence of enzyme activity, there 
is a basal non-specific reaction occurring, which accounts for 
more than 50% of the maximum integrated extinction achieved after' 
full gastrin stimulation. 
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8: 6: 2: Carbonic Anhydrase Inhibition: 
In the second study, acetazolamide (1o- 5M) was added to the sections 
with each dose of gastrin. Again there was complet e inhibition of the 
gastrin response (Fig. 8:8). The basal, uncatalysed reaction 
again accounted for more than 50% of the peak percentage integrated 
extinction induced by the maximum dos e of gastrin. 
8:6:J: The Effect of Anoxia on Carbonic Anhydrase Ac tivation 
Acid secretion is asso c iated with an inc rease in oxy g e n utilization 
by the parietal cell. Furthermore, in the pre s e n ce of anoxia, 
a c id secretion in isolated amphibi a n mucosa is inhibit e d (Hersey 
and High, 1972). 
In order to exa mine the effect of anoxia in th e sy s t e m, tissue was 
t r eated with g a st r in in the usual ma nner, whil e und e r a nitrogen 
atmosphere. Sec ondly, the tissue was kept in a nitrog e n atmosphere 
for ten minutes and then treated with gastrin five minut e s after 
removal of th e nitrogen. The gastrin effect wa s almost entirely 
inhibited by the pre s e n ce of anoxia. (Fig. 8:8). In th e tissue 
that was allowe d to recover after ten minutes of anoxia, there was 
partial but inc omplete recovery of the gastrin e ff ec t. 
8:6:4: Discussion: 
It thus appe a r s that the staining r eac tion consists of two, 
approximately equal parts. Firstly a basal unc a talys e d reaction 
which accounts for 50-60% of the ma ximum reaction achiev e d and 
secondly, a re a ction whi c h is inhibited by boiling and by a CA 
inhibitor. Thus, by implication, the second part of this reaction 
is CA mediated. 
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The question arises why the uncatalysed reaction seems to pre-
dominate. The answer probably lies in the staining method. In 
Hansson's method for cytochemical localization of CA, the reagents 
were made up in distilled water and were not buffered. The use 
of buffer made it necessary to increase the concentration of 
cobalt in the reaction medium six-fold, as the buffer competes 
with the cobalt to trap the hydroxyl ions produced in the reaction 
(Loveridge, 1978). This increas e in cobalt, coupled with the 
de-bubbling of the reaction of the react ion medium prior to use 
which accelerates the uncatalysed reaction, re s ults in a high non-
specific staining. However, as the secretagogue-induced increase in 
CA activity could always be clearly detected over a nd a bove the 
non-specific staining this was accept a ble. In a ddition the non-
specific staining remained approximately constant between 
experiment~ and did not materially alter sensitivit y or reproduci-
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FIG. 8:8: Effect of acetazolamide (10- 5M) , boiling the tissue 
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THE EFFECT OF THE ACID SECRETAGOGUES ON 
CARBONIC ANHYDRASE ACTIVITY 
9: 1: INTRODUCTIO~: 
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Under physiological conditions carbonic anhydrase (CA) appears to 
be necessary for the maintenance of neutral intracellular pH in 
the parietal mucosa of the stomach (O'Brien, Rosen et al, 1977, 
Davenport, 1977). Through the action of this enzyme system, CO
2 
- + is hydroxylated to HC0
3 
and H (Maren, 1967). The bicarbonate 
ions are exchanged for Cl at the nutrient membrane of the cell, 
accounting for the 'alkaline tide' of acid secretion (Davenport 
1977), while the H+ions replenish the intracellular H+ pool (Fig. 
6:1). Thus under physiological conditions CA activity may be regarded 
as an index of parietal cell function. 
Acid secretion is mediated by hormonal, paracrine, neurocrine and 
luminal factors which include the three major acid secretagogues 
histamine, acetylcholine and gastrin. (Soll and Grossman, 1978). 
The aim of this section of the study was to demonstrate the effects 
o~ these secretagogues bn CA activity in guinea pig parietal 
mucosal sections quantitated by the method described above. 
9:2: Gastrin: 
9:2:1: Time Course of Gastrin-stimulated CA Activation: 
9:2:1:1: Method: 
To demonstrate the optimal time exposure of gastrin to stimulate 
CA activity, the sections were treated with three concentrations 
-14 -13 -12 of gastrin (2.5 x 10 , 2.5 x 10 and 2.5 x 10 mol/1) for 
JO, 60, 90, 120, 150, 180 and 240 seconds. At the end of these 
time periods the reaction was terminated by the addition of the 
staining reagents. 
Gastrin caused a mean peak activation of CA 90 seconds after 
treatment at each concentration tested. (Fig. 9:1). Following 
the peak at 90 seconds there was a rapid fall in CA activity. 
With gastrin concentrations 2.5 x 10-
12
mol/l this fall was 
significant at 120 seconds (p <0.01) while with gastrin 
concentrations 2.5 x 1o- 13 mol/l, the fall was significant at 
150 seconds (p <0.001). The activity then returned to basal 
levels. 
In view of the finding of peak CA activity occurring at 90 
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Fig. 9:1: Time Course of Activation Following Exposure of 
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9:2:2: The Dose Response Effect of Gastrin on CA Activity. 
9:2:2:1: Method: 
-16 -10 The effects of gastrin 2.5 x 10 to 2.5 x 10 mol/1 on CA 
activity was tested after a gastrin exposure time of 90 seconds. 
The results were plotted relating the mean integrated extinction 
to the log dose of gastrin. Gastrin was tested in 10 experiments 
(9 animals) and a regression line, calculated by the least mean 
squares methods (Appendix 2), was fitted to the data on the linear 
portion of each dose response curve. 
The mean basal activity was calculated by measuring the mean 
extinction of control sections treated with buffer alone during 
the same experiments. The point of intersection of the linear 
regression lines with the mean basal CA activity was designated 









-16 Fig. 9:2 shows the mean dose response effects of gastrin (2.5 x 10 
-10 to 2.5 x 10 mol/1) on CA activity in 10 consecutive experiments. 
. -15 
The linear portion of the dose response curve was between 2.5 x 10 
and 2.5 x 10-
12
mol/l. The calculated D . 
min 
+ -15 
was 2.J - 0.2 x 10 
mol/1 (mean~ sem) while the 0
50 
was 78 ~ J.7 x 10- 15 mol/1. The 
mean slope of the 10 curves was 2.35 ~ 0.06 and the coefficient 
of variation of the slopes was 8.7%. The data of the regression 
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Fig. 9:2: Mean Dose Response Curve of Gastrin in 10 Consecutive 





























































































































































































































































































































































































































































































































































































































































































































































































































































9:J The Time Course and Dose Response of Histamine-Stimulated 
CA Activity. 
9:J:1: Method: 
The method of evaluating the time course of histamine-stimulated 
CA activity was similar to that described for gastrin. Histamine 
-14 time course was studied in the concentrations 1.0 x 10 and 
1.0 x lo- 15mol/l, whilst the histamine dose respons e was tested 
17 -12 over the con c entrations 1.0 x 10- to 1.0 x 10 mol/1 in 12 
consecutive experiments (9 animals). The methods of calculating 
the D . and 0
50 
are described above. min 
9:J:2: Results: 
The time cours e of CA activa tion following exposure to histamine 
is shown in Fig. 9:J. In contrast to gastrin, the increase in CA 
-14 activity following exposure to hist a mine 1.0 x 10 mol/1 was 
rapid and was significantly higher than the basal values at JO 
seconds (p = 0.001). The activity then rose slightly but insig-
nificantly, to a peak at 90 seconds and was still significantly 
above basal values at 150 seconds (p<: ~-001). By 180 seconds the 
CA activity had fallen significantly from the peak (p < 0.001) to 
· · 1 - l5 / . . 1 1 near basal levels. Histamine 1.0 x O mol 1 had a simi ar y 
patterned time course, but the maximal activation was lower. 
-17 -12 The dose response curve for histamine (1.0 x 10 to 1.0 x 10 
mol/1) is shown in Fig. 9:4. The maximal effects above basal of 
histamine on CA activity is 62% that of gastrin. The doses 
-16 -14 1.0 x 10 to 1.0 x 10 mmol/1 comprised the linear portion of 







was 5.8 - 0.9 
+ 0
50 
was 76.8 - 7.6 
110 
x 1o- 17mol/l (mean! sem), while 
x 10- 17mol/l. The mean slope of the 
12 regression lines was 1.84 ! 0.07 with a coefficient of variation 
of 13.6%. This differed significantly from the mean slope of 
the gastrin curves (p < 0.01). The regression equations from the 
individual experiments is shown in Table 9.2. 
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FIG. 9:4: The Effect of Histamine on Carbonic Anhydrase 
Activity. Each point indicates the mean~ sem 

















































































































































































































































































































































































































































































































































































































































































































































































































































































9:4: The Time Course and Dose Response of Carbamylcholine-
Stimulated CA Ac __ t_i_v_1_·_t~Y-·~~~~~~~~~~~~~~~~~~ 
9: 4: 1: Introduction: 
The third major physiological stimulant of acid secretion is 
acetylcholine . It was noted at the onset of these experiments 
however, that although acetylcholine stimulated CA activity, the 
response was extremely variable. This was not found to the same 
extent with the analogue carbamylcholine and it was decided to use 
the latter in the following experiments. The reason for the 
variable response to acetylcholine is not kno~n but it is thought 
to be possibly due to rapid tissue degradation of the substance. 
9:4:2: Methods: 
114 
The methods are similar to those de-scribed for gastrin and histamine. 
The time cours e of carbamylcholine -stimulated CA activity ~as 
-9 10 
tested at th e concentrations 1.o · x 10 and 1.0 x 10 mol/1, 
whilst the dose response effect was tested at conc entrations 1.0 
x 10- 13 to 1.0 x 10-
8mol/l in 12 experiments (8 animals). D . and min 
0
50 
were calculated as above from the regression equations. 
9:4:J: Results: 
The time course of CA activity following exposure to carbamylcholine 
is shown in Fig. 9:5. Lik e histamine, carbamylcholine caused a 
significant rise in CA activity by JO seconds (p ~0.05), peaked 
at 90 seconds and then fell. 
-9 
Carbamylcholine-(1.0 x 10 mol/1) 
stimulated activity was still significantly (p <0.01) above 
basal at 240 seconds after stimulation. 
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-10 In contrast carbamylcholine-(1.0 x 10 mol/1) stimulated 
activity had returned to basal at 180 seconds. The dose response 
curve for carbamylcholine(1.o x 10- 13 to 1.0 x 10-
8
mmol/l)is 
shown in Fig. 9:6. The maximal effect of carbamylcholine above 
basal is approximately similar to that of histamine and about 60% 
that of gastrin. 
-12 -9 The doses 1.0 x 10 to 1.0 x 10 mol/1 
comprised the linear portion of the dose response curve. The mean 
D . was 1.2 ~ 0.3 x 1o- 12mol/l (Mean~ sem) and the mean 0
50 
was min 
+ -12 31.3 - 4.3 x 10 mol/1. The mean slope of the· 12 , regression lines 
+ was 1.33 - 0.05 with a coefficient of vafiatiori of 13%~ This 
differed significantly (p< 0.001) from both the gastrin and 
histamine slopes. The data for the individual experiments is shown 
in Table 9.3. 
F-ig. 9:7 compares the dose response curves of histamine, G17 and 
carbamylcholine. If the potencies of the secretagogues are 
compared by comparing the D
O 
histamine is approximately 100 times 
5 s 
more potent than gastrin, while carbamylcholin~ is approximately 
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FIG. 9:7: Comparison of the Dose Response Curves of Histamine, 
G17 and Carbamylcholine. 
Histamine is 100 times more potent than gastrin which is 400 times 
more potent than carbamylcholine. 
Each point represents the mean! SEM 
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9:5: Discussion: 
In this section activation of CA has been demonstrated in response 
to all three of the major acid secretagogues, gastrin, histamine 
and carbamylcholine ·(acetylcholine) in a dose-dependent manner. 
As has been prev~ously discussed, CA may, under physiological 
conditions, be regarded as an index of parietal cell function. 
Acid secretion in the presence of CA inhibition continues at a low 
rate (Maren, 1967), which is equivalent to the rate of formation of 
+ . 
H by the non-catalysed hydroxylation of CO2
• This cannot be 
increased by further histamine stimulation. (Maren, 1967). 
All three agents in this system have · an effect on CA activity in 
surprisingly low concentrations. Gastrin affects CA a c tivity in the 
dose range 2.J x 10-
15 to 2.5 x 1o-
12mol/l which is about 10-fold 
lower than the level of circulating gastrins in normal fasting serum. 
Thus it could be argued that the carbonic anhydrase activation in 
this system does not reflect physiological acid secretion as if that 
were so, the parietal cell would always be under maximal gastrin 
stimulation. This may be so but on the other hand there is little 
data on the concentrations of these substances at the cellular 
receptor level. As peptide degradation occurs in the tissues, the 
concentration within the serum may not reflect the concentration 
reaching and activating the cells. In this particular syste~, the 
active substances are delivered directly onto the cell sections and 
this may account for the sensitivity achieved. 
The finding that histamine caused a maximal effect which was only 
62% that of gastin, may be comparable to the findings of Adashek 
and Grossman (1963), who found that maximal acid secretion 
stimulated by histamine was only 58% that of gastrin in rats. 
In dogs (Johnson and Grossman, 1969) however, and in man 
. 121 
(Brooks, Johnson and Grossman, 1970), histamine and gastrin have 
a similar maximal effect on acid secretion. Carbamylcholine 
has approximately the same efficacy as histamine. However the 
most potent activator of CA is histamine, followed by G17 and 
lastly, carbamycholine. 
The optimum time course of the secretagogue reactions, i.e. 90 
seconds, is very short compared to other experimental models. In 
the cytochemical method for gastrin described by Loveridge, 
Bloom et al 1974, the optimal time course for CA activation was 
5 minutes, while the maximal binding of (
125 1)-gastrin (Del Mazo 
and McGuigan, 1976) and (JH)-gastrin to isolated parietal cells 
(Soumarmon, Cheret and Lewin, 1977) occurs about JO to 40 minutes 
after exposure. Once again the short activation time in the 
present study may be partly due to placing the secretagogue directly 
onto the surface of these sections. With histamine and carbamyl-
choline the activation time was even shorter, although maximal 
activation also occurred at 90 seconds. Forte, Machen and Forte 
(1977), showed that JO seconds after the addition of histamine to 
isolated piglet mucosa, there was a change in the intracellular 
potential difference. This is thus comparable with the present 
study. They found that the earliest morphological changes 
attributable to acid secretion appeared at J minutes, while acid 
secretion per se was detectable at 5 - 10 minutes. This is about 
similar to the delay in acid secretion in vivo after the intra-
venous injection of histamine (Brooks , Johnson and Grossman 1970; 
Grossman and Konturek, 1974). 
Furthermore, Domschke, Domschke et al (1973), found that cyclic 
AMP in the isolated perfused rat stomach doubled within 60 
seconds of histamine administration. Acid secretion occurred only 
after a lag period of 4 minutes. CA may therefore be activated 
early after stimulation of the cell and the short time course 
noted may correspond to the onset of intracellular acid production 
rather than to the intraluminal acid secretion. Although there 
are no data similar to that of Forte, Machen and Forte (1977) 
regarding gastrin-stimulated acid secretion, heptadecapeptide 
gastrin, when injected intravenously into humans also caused acid 
secretion within about 10 minutes (Walsh, Isenberg et al (1976). 
Thus it appears that histamine and gastrin have approximately 
similar time courses, both in acid secretion in vivo and in the 
maximal activation of CA in vitro. 
The fall in CA activation after 90 seconds noted with all three 
agonists cannot be easily explained. It is possible that this 
reflects an auto-regulatory phenomenon, either within the cell or 
at the respective receptors. An inhibitory action of large doses 
of gastrin (Prugh, Schorr et al, 1975) o~ gastrin extract 
(Gillespie and Grossman, 1964) has been previously described. 
Prugh, Schorr et al, postulated two orders of receptors for 
gastrin on the parietal cell - a high affinity stimulatory 
receptor and a low affinity inhibitory receptor. Furthermore, an 
autoregulatory mechanism for gastrin has been proposed in another 
experimental model. Morgan, Schmalz et al, (1978) have shown that 
heptadecapeptide gastrin increases the amplitude and frequency of 
spontaneous action potentials in canine smooth muscle. 
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With increasing doses of gastrin there was apparent fall in the 
amplitude from the peak achieved at approximately to-9M. These · 
workers suggested that the bell-shaped dose response curve may 
indicate that gastrin and pentagastrin were autoregulatory. However 
these conclusions were purely speculative. 
Likewise the total acid secretory response to very large doses of 
histamine may be less than the total acid output obtained with 
lower doses, (Marks, Komarov and Shay, 1960). Furthermore when 
histamine is infused into dogs for a prolonged period, acid 
secretion tends to fall (Johnson and Grossman, 1969). This may be 
due to a desensitization effect of the histamine rec e ptor in the 
presence of large doses of histamine, but could also reflect an 
autoregulatory mechanism. However, whether this is relat e d to the 
fall in CA activity which occurred after peak histamin e stimulation 
is speculative. 
Much of this discussion has thus proved to be spe culative and 
perhaps it can be rightly argued that at present th e physiological 
relationship of CA activation in this model and quantitative acid 
secretion by the parietal cell is at best, obscure. However, in 
view of the known physiological role of CA, in view of the time 
course of activation whi c h closely reflects the time course for acid 
stimulation and in view of the activation of the enzyme system by 
specific acid secretagogues acting vi a independent mec hanisms, which 
will be discussed in the following c hapter, it is probable that 
this relationship does exist. 
It is possible for example, that the model reflects an early 
event occurring at the initiation of activation of the parietal 
cell mechanisms which eventually leads to acid secretion. 
Whatever this relationship is, however, this technique appears to 
provide a valid model for secretagogue-parietal cell interaction 




THE INTERACTION BETWEEN THE ACID SECRETAGOGUES 
10: 1: Introduction: 
In 1938 MacIntosh proposed that the liberation of histamine in 
gastric mucosa might mediate the secretagogue action of vagal 
stimulation while in 195 6 , Code contended that histamine was the 
final common chemostimulator of acid secretion. According to this 
hypothesis, histamine is the agent which stimula·tes gastric acid 
secretion. Gastrin and cholin e rgic agents stimulate gastric acid 
125 
secretion solely by increasing the availability of histamin e . This 
hypothesis was supported by Black, Duncan et al (1972), who synthe-
sized the first histamine H
2
-receptor blocker, burimamide and its 
successors me tiamide and cimetidine (Brimblecombe , Dunc an e t al, 
1978). Thes e ag ents caused a reduction in both basal (by about 50-
90%) (Sewing, Hagie et al, 1978; Richardson, 1978) and stimulated 
(80-95%) acid secretion (Sewing, Hagie et al, 1978; Richardson, 
1978; Grossman and Konturek, 1974; Richardson, Bailey et al, 1975). 
Grossman ( 1975) suggested that there ar_e at least three stimulatory 
receptors in the parietal cell membrane (histamine, gastrin and 
acetylcholine); and that even in the resting state some of these 
receptors are occupied by their respective agonists; and that 
each agent permissively allows the full action of the others 
while conversely, blockade of the receptors for any on e of these 
agents will depress the response to the other stimulants. 
Soll (1978a, b, 1980a) found that histamine, carbamylcholine and 
gastrin could independently cause an increase in oxygen uptake and 
( 14c) · · · 1 · · · · · 1 11 -am~nopyrine accum ation in isolated canine parieta ce s. 
126 
Histamine potentiated the effect of the other two agents, while 
gastrin alone had a small effect only in large concentrations 
(1o- 7M) and only in the pr~sence of a background of the phospho-
diesterase inhibitor isomethylbutylxanthine. 
As has been demonstrated above, carbonic anhydrase (CA) activity 
in guinea pig parietal cells increases with exposure to all three 
of these stimulants. In this section e xperiments will be described 
aimed at demonstrating the interrelationships between these agents 
in the stimulation of carbonic anh ydrase activity. In addition 
the effects of the histamine H
2
-receptor blocker c imetidine and 
the anti-cholinergic agent atropine on secretagogue-stimulated 
CA activity will be shown. 
Lastly, since Soll (1979) has postulated that hist a mine acts via a 
cyclic-AMP mechanism, whereas acetylcholine acts via calcium 
transfer, the effects of lanthanum chloride on secretagogue action 
will be shown, to confirm the independent modes of action of these 
agents. Lanthanum chloride displaces calcium from cell membranes 
and stops calcium fluxes ~cross membranes (Hellman, Sehlin and 
Taljedal, 1976 ) and thus effectively blocks activation dependent 
upon extracellular calcium. 
10:2 Methods: 
10:2:1: Secretagogue Interaction 
In order to investigate whether a potentiating relationship existed 
between the secretagogues, a dose of each agent which was below . 
the calculated minimum dose (Chapter 8) and which thus had no 
significant effect on carbonic anhydrase activity itself was added 
to each dose in the dose response curves of the other agents. 
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The sub-threshold doses were: gastrin 2.5 
-16 
rnol/1, histamine X 10 
1.0 -17 mol/1 and carbamylcholine 1.0 
-13 
rnol/1. The X 10 X 10 
time exposure was 90 seconds for all experiments as this coincided with 
the peak activation induced by all three substances. Dose response 
curves were plotted as previously described and the mean D . , 0 50 min · 
and slopes were compared to those of the agonist alone. 
10:2:2: Secretagogue Inhibition 
To test the effects of an histamine H
2
-receptor blocker, cimetidine 




histamine (1.0 x 10 to 1.0 x 10 mol/1) and to carbamylcholine 
-9 -12 
(1.0 x 10 to 1.0 x 10 mol/1). This large concentration of 
cimetidine was chosen with the aim of blocking all H2
-receptors in 
the tissue. To ensure that cimetidine did not alter CA activity 
independently of gastrin and histamine, cimetidine (1o- 5M) was also 
added to the tissues alone and CA activity measured. The anti-
cholinergic agent atropine (10- 5M) was similarly added to the tissues 
in the absence and presence of each concentration of gastrin, 
histamine and carbamylcholine and the tissue processed in the 
routine manner. Lastly, 
. -6 
lanthanum chloride (10 M) was added to 
the tissues in the presence of each concentration of secretagogue, 
The maximal rise above basal enzyme activity stimulated by the 
agent alone was considered 100% and inhibition was calculated 
from the reduction of this rise caused by the inhibitory agent. 




10:3:1: The Interaction Between the Secretagogues: 
The effects on CA activity of adding a subthreshold dose of 
( X 10-17M) to -15 -11) histamine 1.0 gastrin (2.5 x 10 to 2.5 x 10 
(four experiments) compared with the effects of gastrin alone 
are shown in Fig. 10.1. The mean integrated extinction of the 
-15 
two curves differ significantly at gastrin concentrations 2.5 x 10 
-14: -13 -12 
and 2.5 x 10 mol/1 (p < 0.01) and at 2.5 x 10 and 2.5 x 10 
mol/1 (p < 0.05). There was no significant difference at the 
highest concentration of gastrin (2.5 x 10-
11 
mol/1). 
The regression equations of the individual dose curves of gastrin 
with subthreshold histamine are shown in Table 10.1. · The mean (! SEM) 
slope i; 2.12 ! 0.06 and the coefficient of variation of the slope 
is 6%. The added histamine caused a significant reduction in both 
the D . and the 0
50 
of the gastrin dose responses and a signifi-
m1.n 
cant alteration in the slopes of the regression lines. (Table 10.2). 
-16 
Similarly, the addition of gastrin (2.5 x 10 mol/1 to the 
histamine dose response curve (1.0 x 10-
17 to 1.0 x 10- 13 mol/1) 
(four experiments) caused a significant reduction in the 0 50 and 
D . foi histamine (Table 10.2). Fig. 10.2 shows that the sub-
min 
threshold dose of gastrin significantly increased the mean 
integrated extinction, at all concentrations of added histamine. 
The data of the individual dose response curves of histamine with 
subthreshold gastrin is shown in Table 10.1. The mean slope is 
1.12 ! 0.13 with a coefficient of variant of 22%. This differed 
significantly from the mean of the histamine slopes (Table 10.2). 
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In contrast neither the addition of subthreshold concentrations 
of gastrin nor subthreshold histamine to the carbamylcholine 
dose response curves significantly altered the D or D . of 
50 min 
carbamylcholine (Fig. 10.J). (Table 10.2). Likewise, carbamylcholine 
did not significantly alter the histamine dose response curve 
(Fig. 10.~) but did slightly reduce the maximal effect achieved by 
gastrin alone (Fig. 10.5). This occurred without significantly 
altering the D . or n
50 
of the gastrin response (Table 10.2). 
min 
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10.J.2. Secretagogue Inhibition 
Cimetidine (10- 5M} alone had no effect on the basal CA activity 
of the parietal cell sections. The effect of cimetidine on 
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histamine-stimulated CA activity is shown in Fig. 10.6. Cimetidine 
caused 76~ 7.8% inhibition of hist a mine-stimulated CA activity 
at the maximal effective dose of histamine (1.0 x 10-
14
mol/l}. 
Gastrin-stimulated CA activity was only slightly affec ted by 
cimetidine (Fig. 10.7}. The D . of gastrin and cimetidine was min 
+ -15 . 
1.7 - O.J x 10 mol/1 and was not signifi c antly diff e rent from 
that of gastrin alone. However the slope of the g a st r in dose 
+ 
response curve was a 1 t e red ( 1. 6 8 - O • 2 ) ( <; O • O 1 } • At the maximal 
effective dos e of gastrin (2.5 x 10-
12 mol/1), cim e t i din e inhibited 
+ 
gastrin-stimulated CA activity by 23 - 4% (p < 0.01). 
Carbamylcholine-stimulated CA activity was no t significantly altered 
by cimetidine (Fig. 10.8). 
Atropine did not alter basal, histamine, or gastrin-stimulated 
CA activity (Fig. 10.9). Atropine however markedly inhibited 
carbamylcholine-stimulated CA activity with total inhibition at 
-11 -10 + o1_ 
concentrations 1.0 x 10 and 1.0 x 10 mol/1 a nd 79 - 9~ 
inhibition at the maximal effective dose of c a rbamylcholine (1.0 x 
-9 10 mol/1) (p < 0.001). (Fig. 10. 10) • 
The effects of atropine and cimeti d ine on gastrin-~ histamine-, and 
carbamylcholine-stimulated CA activation are compared in Fig. 10.11." 
-6 
Lastly, the effects of lanthanum chloride (10 M) on gastrin 
(2.5 
- 12 -14 
x 10 mol/1) histamine- (1.0 x 10 mol/1) and carbamylcholine 
( 1.0 x 10-9 mol/l) stimulat e d CA activation is shown in Fig. 10.12. 
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Carbamylcholine- (1.0 x 10-9m0l/l) stimulated CA activity was 
+ -12 
inhibited by 77 - 8% (p < 0.001) gastrin (2.5 x 10 mol/1) by 
+ -tl.1c . + 
45 - 10% (p < 0.01) and histamine (1.0 x 10 mol/1) by 2 - 9% 































+Cimetidine (1 o5M) 
HISTAMINE (mol/l) 
The effec t of cimetidine (10- 5M) on histamine-stimulat e d CA 
activity. 
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Each point represents th e mean - SEM 
A p < 0.01 
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FIG. 10: 11 
Percentage inhibition(! SEM) of carbamylcholine (1o- 5M) and 
atropine (1o- 5M) on histamine- (H) (1.0 x 1o- 14M), gastrin- (G) 
-12 9 (2.5 x 10 M) and carbamyl c holine- (C) (1.0 x 10- M) stimulated 
CA activity. 
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Potentiation refers to the phenomenon in which the effect of 
two agents in combination is significantly greater than the sum 
of the effect of each agent alone (Gardner, Jackson et al, 1978). 
This can occur in two ways, by an increment in efficacy or an 
increase in potency. "Efficacy" refers to the magnitude of a 
response caused by a maximally effec tive concentration of a 
particular agent. "Potency" refers to the concentration of a 
particular agent required to produce an effect of given magnitude, 
e.g. the conc~ntration required to produce a half maximal response 
(Gardner, Jackson et al, 1978). Thus the incre as e in t h e maximal 
effect and the shift to the left of the histamine r e spons e caused 
by a dose of gastrin, which itself had no significant effect, 
is suggestive of potentiation due to both an increas e in efficacy 
and potency, while the shift to the left of the dose response of 
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gastrin caused by a subthreshold dose of histamine may be interpreted 
as a potentiating effect due to an increment in potency. 
These results are therefore not wholly comparable to those of 
Soll (1978a,b, 1980a) who showed by oxygen and (
14
c)-aminopyrine 
uptake in isolated canine parietal cells that histamine increased 
the efficacy of the response to gastrin. However, Soll's data 
indicated that increased potency had also occurred in his model 
as the lowest dose of gastrin alone to cause an effect was 10- 7 M 
-10 whilst gastrin 1u M enhanced the effect of histamine. 
In further contrast to Soll's findings (1978a,b 1980a) this present 
work did not demonstrate significant potentiating interactions 
between histamine and carbamylcholine. 
Although both the carbamylcholine and histamine dose response 
curves tended to be shifted to the left by subthreshold histamine 
and carbamylcholine respectively, this did not achieve statistical 
significance. Subthreshold gastrin furthermore did not alter 
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the carbamylcholine curve but it was interesting to note that the 
subthreshold carbamylcholine caused a small decrease in the magni-
tude of the maximal gastrin response, thus apparently decreasing the 
efficacy without a significant alteration in the potency. The 
significance of this is unknown and it may be spurious since it 
was demonstrated at only a single point. 
Soll (1978ab, 1980a} found no potentiating interaction between 
gastrin and carbamylcholine in his isolated cells. Gastrin and 
histamine have been demonstrated to potentiate each other in vivo, 
(Brooks 1 Johnson and Grossman, 1970; Johnson and Grossman, 1969} 
whilst acid secretion following antrectomy, which removes the major 
source of gastrin, is decreased in response to histamine (Bergegardh, 
Broman et al, 1976}. Further evidence for secretagogue interaction 
is the finding that both H2
-receptor antagonists (Grossman and 
Konturek, 1974; Black, Durican et al, 1972; Brimblecombe, Duncan 
et al, 1974; Sewing, Hagie et al, 1978; Richardson, Bailey et al, 
1978) and anticholinergics such as atropine (Konturek, Oleksy and 
Wysocki, 1968; Hirschowitz and Sachs, 1969} block the effects of 
secretagogues other than their specific agonists. These reports 
contrast with the present findings that atropine, which inhibited 
carbamylcholine-stimulated CA activit y , had no effect on either 
the gastrin or histamine-stimulated CA activity, while cimetidine 
inhibited only 23% of the gastrin effect, 7% of the carbamylcholine 
effect and 76% that of histamine. 
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In addition, in vivo potentiating interactions between gastrin 
and cholinergic agents (Grossman, 1974) and between cholinergic 
agents and histamine (Gillespie and Grossman, 1964b; Johnson and 
Grossman, 1969) have been demonstrated. The reason why this 
interaction is not apparent in-vitro systems . is not known. It is 
possible that the interactions may be three-way interactions 
(Soll, 1978c), a possibility which has not been tested in this 
study or there may be species differences. Grossman (1975) 
suggested that all secretagogues act on their own receptors in 
the parietal cell, but the action is diminished if the other 
receptors are not occupied simultaneously. This could explain the 
slight reduction noted in the maximal effect of gastrin caused 
by cimetidine which may have been due to blockade of endogenous 
tissue histamine acting together with the gastrin to produce 
the gastrin effect. However this data indicates relative 
independence of the cholinergic pathways from that of gastrin and 
histamine in guinea pig mucosa. 
The finding that lanthanum chloride inhibits carbamylcholine-
stimulated but not histamine-stimulated CA activation is very 
similar to the findings of Soll (1979). Thus Soll has suggested 
that carbamylcholine acts via a calcium pathway, whereas histamine 
acts via cyclic AMP (Wollin, Soll and. Samloff, 1979), This again 
implies a separation of the pathways of secretagogue action. 
Lastly, in spite of the inhibition of both gastrin and acetyl-
choline stimulated acid secreti~n by the H2
-receptor antagonists 
there has also been recent suggestions that anticholinergic 
agents augment the acid inhibition achieved by cimetidine in 
duodenal ulceration (Feldman, Richardson et al, 1977), whilst 
149 
vagotomy reduces the cimetidine inhibition of acid in the 
Zollinger Ellison syndrome. (Richardson, Feldman et al, 1979). 
This is thus a further clinical demonstration of the secretagogues 
acting through individual but interdependent pathways. 
Thus it is clear that neither the isolated cell system of Soll, 
nor the quantitative cytochemical technique, is able to answer all 
the questions regarding secretagogue interaction. However this 
work and that of Soll's, both demonstrate an independent action 
by all three secretagogues, a potentiating interaction between 
gastrin and histamine and distinctly separate modes of action, 
although details of the latter are still not clear. Furthermore 
this independence of action and the potentiation between gastrin 
and histamine is not compatible with the final common pathway 
theory of Code (1956) and suggests that H2-receptor b
lockers 
inhibit acid secretion by inhibition of the potentiation effect 
of histamine rather than by blockade of gastrin-or cholinergically 
mediated histamine release. 
CHAPTER 11: 
COMPARATIVE POTENCY OF THE GASTRINS 
11:1 Introduction: 
Thus far the effects of synthetic non-sulphated heptadecapeptide 
gastrin (SHG-17-I), histamine and carbamylcholine on carbonic 
anhydrase (CA) activity in the parietal cell sections have been 
examined. Histamine is the most potent activator of CA with 0 50 
approximately 100 times lower than G17 and carbamylcholine, the 
least potent agonist, with a 0
50 
approximately 400 times higher 
than G17. 
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The gastrins are composed of several molecular forms including 
"big · gastrin" comprising J4 amino acids (GJ4), Big-big gastrin (BBG) 
and component I of undetermined molecular structure, "little gastrin'' 
(G17) and 11 mini-gastrin" (G14) (Walsh and Grossman, 1975). In 
addition the carboxyterminal tetrapeptide common to gastrin and 
CCK (CCK-4) has been found to be present in the nerves of the gastro-
intestinal tract (Larsson and Rehfeld, 1979). These different forms 
have different potency in acid secretion (Strunz, Thompson et al, 
1978). As the gastrins are present in the circulation, the potency 
of these molecules is dependent not only upon their actions at the 
cellular level but also on their fate within the circulation. In 
the cytochemical bioassay the latter variable is not a factor and 
the technique therefore may be used to measure potency at a cellular 
level. In this chapter the potency of several gastrin peptides on 
the activation of CA are compared. 
11:2 Methods 
11:2:1: Laboratory Methods 
The method for quantitative cytochemical estimation of CA activity 
is as previously outlined. 
The standard reference preparation for all these studies was 
15 -12 
SHG-17-I in doses ranging from 2.5 x 10- ~o 2.5 x 10 -- mol/1 
and the potency of the following substances in the activation of 
CA was compared: 
1. Natural human gastrin 17-I (NHG 17-I)* 
2. Natural human gastrin 17-II (NHG 17-II)~ 
3. Natural human gastrin 34-I (NHG 34-I)* 
4. Synthetic amino-terminal gastrin fragment 1-13 (G 1-13) + 
5. Synthetic carboxy-terminal fragment 8-17 (G 8-17) + 
6. Synthetic cholecystokinin octapeptide (CCK-8) (SQ 19844) 
(donated by Dr. Ondetti, Squibb Laboratories, U.S.A.) 
7. Synthetic pentagastrin (PG) (Imperial Chemical Industries 
( IC I) U. K.) 
11:2:2: Statistical Analysis 
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In bioassay systems the presence of parallelism between the standard 
dose response curve and several dilutionn of the test substance 
implies that the test substance contains the same material or 
another material acting in an identical manner to that present in 
the standard preparations (Cornfeld, 1964). In contrast, the 
absence of parallelism implies that the response of the test 
substance is being affected by another substance which may either 
inhibit or enhance the effect of the material being measured or 
that the test material is dissimilar to the standard preparation. 
• These peptides kindly donated by Dr. M. Grossman of CURE 
Los Angeles, were isolated from tumour extracts prepared 
by Drs. Gregory and Tracy. 
+ These peptid~s were kindly donated by Dr. J. Morley of ICI. 
However the presence of parallelism does not necessarily exclude 
the presence of a co-existing inhibitor which may be diluting 
out in the same manner as the effector substance over the range 
of dilutions tested. 
In this study, because the different peptides did not in all 
cases cause identical maximal or parallel dose responses, the 
relative potencies were calculated from the 0
50 
of the substance 
relative to the 0
50 
of SHG 17-I expressed as a percentage(! 95% 
confidence limits) (Appendix 2). The mean basal enzyme activity 
was calculated by measuring the mean integrated extinction of 
control sections treated with buffer alone. The slopes of the 
dose response curves were determined by regression of the (MIE x 
100) against the log
10 
peptide concentration by least mean squares 
analysis (Appendix 2). Parallelism of regression lines was 
assessed by analysis of covariance (Appendix 2). 
Results: 
. I 
The potencies of the gastrin-like peptides are compared in Table 
11.1. The dose ~esponse · effect of SHG 17-I was parallel to that 
of NHG 17-I, NHG 17-II, G 8-17, PG and CCK-8 but differed signi-
ficantly from that of NHG 34-I (p< 0.01). The standard mean dose 
response curve of NHG 34-I is compared to that of SHG 17-I in 
Fig. 11.1. 
The N-terminal peptide G 1-13 had no biological activity whereas 
the C-terminal decapeptide G 8-17 had similar potency to SHG 17-I. 
The dose curves of G 1-13 and G 8-17 are compared in figure 11.2. 
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FIG. 11: 1 
Comparison of the dose response curves of the SHG-17-I (G17) 
and NHG-34-I (GJ4). 
Each point indicates the mean and SEM of 6 pooled experiments. 
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The potency of acid secretagogues as agonists of parietal cell 
function is dependent upon events at the cellular level and in 
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the instance of circulating substances, on the fate of the 
substance within the circulation. At the cellular level the potency 
of agonists is dependent upon:-
(a) The nature of interaction with the receptor ~pon which 
the substance acts, including, the affinity of. the 
substance for the receptor. 
(b} The degradation and removal of the substance from the 
system. 
(c) Post-receptor cellular events. 
The potency of systemically administered agoni s t is dependent upon 
events at the cellular level and in addition the route and manner 
of administration into the system. Thus GJ4 and G17 when infused 
in equimolar concentrations are equipotent in causing acid secre-
tions (Walsch, Isenberg et al, 1976), which is supported by these 
findings of similar potencies at the cellular level. However, as 
GJ4 has a half-life disappearance time six times longer than 
G17 (Walsch, Isenberg et al, 1976) which results in a higher 
circulating blood level, these workers calculated that GJ4 was 
six times less potent than G17 at the cellular level. This 
calculation may be erroneous as a later study by the same group 
(Feldman, Walsch et al, 1978), shows that ~11 gastrin-stimulated 
acid secretion after a peptone meal is attributable entirely to 
G17 in spite of the high circulating GJ4 levels. This suggests 
that the gastrins in circulation may not have the expected 
biological effects on acid secretion, thus rendering potency 
calculations from blood levels and half life disappearance 
times rather unreliable. 
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In this study it was found that GJ4 and G17 had similar potenci
es 
in activating CA. However, their actions, as determined by non-
parallelism of the dose response curve, were not similar. The 
reason for this is not clear. In view of their molecular 
similarities, it is unlikely that these molecules are acting at
 
different receptor sites. It is possible that GJ4 interacts with 
endogenous substances such as histamine in a different manner t
o 
G17 or that the amino-terminal elongation alters the nature of 
the 
interaction with the receptors or hinders degradation at the 
receptor site and thus alters the dose response curves. How
ever, 
this is speculative. Strunz, Thomp s on et al, (1978) have shown 
that 
gastrins of various chain lengths have differe nt pot e ncies • 
depending on whether the peptide is given via the portal or 
systemic route. This is due to different rates of hepatic in-
activation of the peptides. Carboxyterminal peptides of 8 amin
o-
acids or less were more than 90% inactivated by the liver. 
Thus 
in vivo the carboxy-terminal decapeptide of gastrin (G10) has 5
3%, 
and the shorter pentagastrin molecule 12% the potency of G17. F
or 
contrast in the cytochemical bioassay, G10 has a 100% and penta
-
gastrin 33% the activity of G17, a discrepancy possibly due to 
inactivation in the circulation. This data also confirms tha
t 
the aminoterminal of gastrin is biologically inactive at the 
cellular level as well as when given systemically. 
CCK-8 caused activation of CA which was parallel to but less 
potent than that of gastrin. This finding would thus be compati
ble 
with the proposal of Johnson and Grossman (1971) that CCK is a 
partial agonist of acid secretion in certain species. 
In conclusion this work confirms that differences in potency 
of gastrin molecules vary with molecular configuration and that 
the cytochemical bioassay is a method for measuring secretagogue 
potency at the cellular level. In the next chapter the secreta-
gogue potency of the serum of normal subjects will be measured 
by this technique. 
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CHAPTER 12 
THE MEASUREMENT OF CARBONIC ANHYDRASE 
STIMULATING ACTIVIT·Y IN HUMAN SERUM. 
12:1 Introduction: 
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The acid secretory response to a mixed meal is influ e nced by 
numerous interacting factors. Thes e may be both stimulatory or 
inhibitory and act via neurocrine , parac rine, hormonal and 
luminal factors (Soll a nd Grossm a n , 1978). There is poor corre-
lation between the levels of circ ula t ing gastrins and the amounts 
of acid released with a meal. (Ri c h a rd s on, Wa l sc h et a l, 1976). 
On e of the reasons for this may be that gas tr i ns circ ulate as 
several peptides. (Walsch and Grossman, 1975). Th is h e terogeneity 
will have two effects. Firstly, radioimmunoas s ay measurements of 
gastrin will vary according to the specificity of different anti-
sera for different gastrin peptides and secondly the biological 
activity of the various gastrin-like peptides differ. 
After a mixed meal 75 % of the gastrin released is GJ4. The 
remaining 25 % is accounted for by G17 and to a lesser extent G14. 
(Walsch, Isenberg et al, 1976). These workers ca l c ulated that 
G34 probably contributes less th a n half of th e acid stimulating · 
activity of the gastrins released in respons e to a meal. Taylor, 
Dockray and Walker (1979) however reported that 50% of the gastrin 
released after a meal is G17, whilst Lamers, Harrison et al (1979) 
reported that the levels of G34 in the resting state were twice 
times that of G17. Follo·wing a meal, G17 increased four times 
and G34 twice times to give an approximate 1:1 ratio. 
Feldman, Walsch et al, (1978) showed that the G17 released in 
response to a peptone meal could account for all gastrin-
stimulated acid secretion. Thus it appears that the g a st r ins 
released after a meal do not display their expected biological 
effects and this together with the heterogeneity of the gastrins 
ma y account for the dissociation no te d b e tween acid secretion and 
serum gastrin conc entrations measur e d by radioimmuno a ss ay . 
Th e aim of this section of t h e st udy was to examin e th e s ec reta-
gogue potency i n s e rum b e for e and aft e r a mix e d mea l i n normal 
p e ople and in k nown h y p e rgastrin aemic p at i e n ts. 
As has been previously demon s tra t e d gastrin, hi st am i n e a nd a c etyl-
choline are all activators of CA in th e cytoc h e mi ca l bi oa s say, 
and may be present in blo~d. In addition, oth e r acid sec retagogues 
may circulate in blood. For this reason the a ssay may not be 
specific for gastrin and will be considered as a n ass a y for the 
CA stimulating activity (CASA) of serum. 
12:2: Methods; 
12:2:1: Cytochemical Bioassay 
The method is as previousl y desc r ibed. The CA stimulating activity 
(C ASA) of the serum samples diluted 1:100 and 1:1000 in 0.025 Hepes 
buffer pH 7.0 were compared to standard reference solutions of 
synthetic non-sulphated heptadecapeptide gastrin (SHG-17-I) in 
doses ranging from 2.5 x 10-
15 to 2.5 x 10-
12 mol/1. Treatment 
time for both was 90 sec onds. Both standard preparations and 
unknown serum samples were assayed in triplicate within a single 
assay. Thus two unknown samples could b e assayed with each standard 
dose response curve. 
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12:2:2: Assay Variation and Precision 
To assess the variation in measurementof CASA between identically 
tested sections within a single assay (intra-assay variation) 
the CASA of the four standard gastrin concentrations were tested 
on six sections each during one experiment. 
To assess inter-assay v a riation a serum sample was divided into 
aliquots, frozen and a single aliquot measured at 2 dilutions 
(1:100 and 1:1000) in six consecutive assays. Lastly, a furth e r 
estimation of inter-assay variation was calculated from the 
variation of the slopes of the standard dose respons e c urves 
(Appendix 2). 
The index of precision A (G a ddum, 19JJ ) for e ach indi v idual dos e 
response curv e was calculated as follows: 
A = Sxy/M 
where Sxy is th e standard deviation of the individual values about 
the straight regression lin e and Mis the slope of the line. By 
Lorraine's criteria (1958), assays with A of 0.2 or less are 
very precise and well-suited for chemical studies, while assays 
with a A of 0.2 to O.J are less precise but still regarded as 
acceptable. Any dose response curve with a A of more than 
0.27 was regarded as unacc e ptable for the purpose of this study 
and the results were discarded and assays repea t e d. 
In addition the fiducial limits (95 % confidence limits) were 
calculated for each standard curve. ( Appendix 2). Parallelism 
of the dose response curve and the serial serum dilutions were 
c alculated as above. (Chapter 11:2:2) (Appendix 2). 
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If the slope of the dilution curve of the unknown samples did 
not parallel that of the standards on the first experiment, the 
162 
samples were repeated in a second assay and at different dilutions. 
In addition, samples reading beyond the maximum capacity of the 
assay were repeated in greater dilutions so that they could be 
read on the sensitive portion of the c urve. 
Thus in summary the following calculations were made on each dose 
response curve: 
(a) Correlation c o efficient by the least mean squares method (r). 
(b) Slope and standard deviation of the jlope of the regression 
line. (M ~ SD) 
(c) Index of precision ( A ) 
(d) Confidence limits of the curve (95%). 
The assay was repeated on the following criteria: 
(a) If the slope of the standard curve fell outside the 95% 
confidence limits of the mean curve. 
(b) If the index of precision of the standard dose response 
curve or the serial serum dilution curve was greater than 
0.27. 
(c) Non-parallelism with standard dose response curve. 
(d) If the unknown sample read in the insensitive portion of 
the dose response curve. In the case of (c) and (d) the 
sample would be diluted to a greater number of dilutions. 
12:2:J Re c overy of Gastrin from Serum: 
One of the tests of the efficiency of an assay system is to add 
known amounts of the substance measured to the tissue fluid 
being assayed and to measure the substance in both the untreated 
and treated samples. 
In a perfectly efficient system, the amount added should be 
exactly equal to the difference in the measurements between the 
treated and untreated samples, i.e. 100% recovery. If these 
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amounts do not tally there are several possible reasons. Firstly 
the substance may be .unstable in the medium to which it has been 
added. This may result in an activity which is lower than expected. 
Secondly, in a bioassay system, the biological activity may be 
altered by interfering substances. Lastly, it may reflect an 
inefficiency in the assay system. The recovery of SHG-17-I in 
the cytochemical bioassay was measured by adding SHG-17-I to a 
fasting serum sample in concentrations anticipat e d to cover the 
range of the assay. These samples were also measured by radio-
immunoassay using the G2 and 2604/7 antiserum. (Appendix 1).' 
12: J: Specificity of the Cytochemical Bioassay 
Prior to measuring the CASA in the serum of normal and hyper-
gastrinaemic subjects, an attempt was made to characterise this 
activity in serum. This was done by the removal of gastrin from 
serum in two ways. 
(1) Charcoal Adsorption 
(2) Adsorption on a specific affinity chromatography column. 
Both these techniques were performed on pooled fasting serum as 
described in Appendix I. 
12 :J: 1: Activated Charcoal Adsorption 
Activated charcoal added to serum adsorbs peptides and small 
molecules. In a 2% suspension the charcoal will remove the 
majority of gastrin 17 and gastrin J4 from the serum. However 
big-big gastrin (BBG) which elutes in the void volume of a 
sephadex G50 column and has a molecular weight of 20,000 is not 
affected by charcoal treatment. 
(Yalow and Wu, 1973). This differential removal by charcoal of 
small small from large peptides is used in the gastrin radio-
immunoassay to separate free (
125 1)-gastrin from antibody bound 
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lfl2 
Effect of serial dilutions of charcoal treated serum and serum purged 
of gastrins by affinity chromatography on CA activity as compared 
to the gastrin dose response curve. 
12:J:2 Affinity Chromatography 
Affinity chromatography is a method of adsorbing a specific 
substance from a solution o r suspension. In order to do this 
a ligand is required which is specific for that substance. A 
convenient ligand for the adsorption of a peptide is an antiserum 
di~ected against that peptide. For this purpose an anti-gastrin 
antiserum G9 prepared by the inoculation of a rabbit with SHG 17-I 
coupled to whelk haemocyanin was used (Napier, 1978). This anti-
serum which cross-reacted with both natural and synthetic human 
gastrins G17 and GJ4 was coupled to AH Sepharose (R) 4B (Pharmacia 
Fine Chemicals, Uppsala, Sweden) using carbadiimide as the coup-
ling agent by the method of Cuatrecasas(1970). (App e ndix 1). 
12:J:J: Results: 
The effects of serial dilutions of untreated serum is shown in 
Fig 12.1. This is compared to serum treated by charcoal 
adsorption and affinity chromatography in Fig. 12.2. CASA was 
removed by both forms of treatment and parallelism with the 
standard dose response curve was lost. In contrast the radio-
immunoassay gastrin was reduced from 17.5 pmol/1 in the untreated 
serum to 12.5 pmol/1 in the charcoal treated serum and to undetect-
able levels in the affinity chromatography serum. 
12:J:4. Discussion 
The finding that the removal of gastrin from fasting serum 
coincided with the removal of most of the CASA of serum suggested 
that gastrin plays a major role in this activity. 
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Nevertheless it should be stated that neither experiment confirmed 
absolutely the specificity of serum gastrins in accounting for the 
CASA of serum. Firstly charcoal adsorption is not a specific 
gastrin adsorbent and other molecules may be removed by this 
treatment. Secondly, whereas affinity chromatography may be a 
specific technique for adsorbing gastrins, the possibility of the 
degradation of other sm a ll molecules such as histamine and acetyl-
choline occurring during the affinity chromatography tr e atm e nt 
cannot be excluded. Both these substances are inactivat e d very 
rapidly in blood (Code, 1977) via the histaminase and diamine oxidase 
enzymes (Baylin, Beaven et al, 1970) and acetylcholin e st e ras e 
respective ly. No spec ific measures to prevent thi s occ urring during 
the affinity chromatography treatment were taken and a s no methods 
sufficiently sensitive for me a suring these sub s t a n ce s we re available 
it is not possible to speculate as to their fate during this 
treatment. 
The finding that charcoal treatment of serum removed only JJ% of 
the immunoreactive gastrins but 100% of the CASA is consistent with 
the finding of Yalow and Wu (1973). They suggested that the pre-
dominant circulating form of gastrin in the fasting state is BBG 
which is not adsorbed by charcoal. Although further studies would 
be required to prove that the remaining immunoreactivity is due to 
BBG, this data suggests that the material non-adsorb e d to charcoal 
is biologically inactive. Whether this BEG repres e nt s a c ircu-
lating large molecular weight prohormone form, or is non-specific 
protein interference, as suggested by Rehfeld, Schwartz and Stadil 
(1977), is still unclear. 
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12:4 Subjects: 
12:4:1: Normal Subjects: 
Ten normal volunteers consisting of 7 males and J females were 
studied. Their ages varied from 18 to 35 years. After an over-
night fast a 19 gauge butterfly needle was inserted into an anti-
cubital vein. This was maintained patent by flushing with a few 
mls. of heparinised saline after drawing blood samples. Venous 
blood was sampled at 15 minute intervals during the JO-minute 
basal period. The subjects then ate a standard breakfast (Table 
12:1) over a period of 10 minutes. Further blood samples were 
taken at 5, 15, JO, 60, 120 and 180 minutes after the mea l. Thes e · 
were separated immediately by centrifugat ion and the s erum stored 
at-20°c. All subjects gave written informed consent. All 
samples were assayed in at least two dilutions by the cytochemical 
bioassay for CASA and by radioimmunoassay using two antisera, G2 
and 2604/7 (Appendix 1). 
12:4:2: Hypergastinaemic P~tients: 
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Ten patients with hypergastrinaemia had fasting serum samples 
analysed for CASA and immunoreactive gastrins. These patients 
included 6 patients with the Zollinger-Ellison syndrome (gastrin-
producing tumours), three of which had Multiple Endocrine 
Adenomatosis Type I. Five of these patients had tumours removed, 
whereas one patient became normogastrinaemic following parathyroid-
ectomy. Four of these patients, including the last mentioned, 
had positive secretin. tests i.e., the serum immunoreactive 
gastrin increased more than 45pmol / l following the intravenous 
injection of 2 u/kg Boots secretin. In addition four patients 
with atrophic gastritis were tested, including three with pernicious 
anaemia and one with dyskeratosis congenita. 
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12:4:J: Statistical Methods: (Snedecor and Cochran, 1967). 
Values were compared using the Wilcoxon Rank test for paired 
samples. Correlation coefficients were calculated by the least 
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12:5 Results: 
12:5:1 Statistical Variations of the Assay 
A dose response curve of gastrin with the calculated 95% confidence 
limits is shown in Fig. 12:J. The data utilized is that in Table 
8: 1. 
The mean index of precision of 44 consecutive standard dose 
response curves was 0.15 with a range from 0.05 to 0.27. The slope 
of the dose response curve in these assays varied from 1.975 to 
2.8889 with a mean of 2.38 and a coefficient variation of 8% . The 
95%confidence limits were therefore calculated to rang e from 
1.998 to 2.768 and assays in which the slope of the standard dose 
response curve fell outside these limits were rep e at e d. 
The interassay coefficierit ~f variation of 6 consecutive assays was 
JO% (Table 12:2), whilst the intra-assay coefficient of variation 
-15 -14 -13 at concentrations of gastrin 2.5 x 10 , 2.5 x 10 , and 2.5 x 10 
mol/1 was 15%, 9% and 19% respectively (Table 12:J). At concentra-
-12 tion 2.5 x 10 mol/1, although the variation in readings was small 
(5.6%), this variation read off the x axis (log conc entration) was 
unacceptably high (100%). This loss of sensitivity at the upper 
region of the curve was overcome b y repeating test samples reading 
in this region in a greater number of dilutions. The lowest 
concentration of gastrin which could be differentiat e d from zero 
with 95% confidence was J x 10- 15 mol/1. 
The recovery of gastrin by the cytochemical bioassay is about 50% 
whereas the recovery measured by the radioimmunoassay was 55% 
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Each sample in the cytochemical bioassay was assayed in two 
dilutions and par:1llelism with the standard dose response 
curve was present in each set of dilutions (Table 12.5). 
12:5:2 Normal Subjects 
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Table 12.5 shows the fasting CASA levels in the serum of the 
normal subjects as measured by cytochemical bioassay. The mean 
fasting CASA level was 15.8 ·: 1.6 pmol/l (SEM) whils t the gastrins 
measured with 2604/7 was 50.4 pmol / 1 and with G2 25.J: 2.8 pmol/1 
(Fig. 12.4) 
The table shows that all fasting s e r a dilut e d out in parallel 
with the SHG-17-I dose response curve. This i s evident by the 
similarity of the measurements at ~he two dilutions te s ted. 
There was a significant c orrelation between the RIA gastrins 
measured with the two antisera in the fasting state (y = 1.15 x + 
41.5, r. = 0.7837 p <0.01) (Fig. 12.5). However, th e re was no 
significant correlation between th e RI A values and CASA values 
in the fasting sera (Fig. 12.5). 
Following the meal there was an immediate rise of immunoreactive 
gastrins. The mean gastrin concentrations measured by the G2 
antiserum were significantly rais e d above basal leve ls, 5 
minutes after the meal (p < 0.01) whilst the values me asured by 
2604/7 were significanty raised above basal 15 minutes after the 
meal. 
The immunoreactive gastrins remained high, reached a peak at 120 
minutes and at 180 minutes, were still significantly raised 
above the basal values (Fig. 12.4). 
In contrast CASA levels rose much more slowly after the meal. 
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CASA was significantly raised above basal at JO minutes and reached 
+ a peak 15.1 - 4.4pmol/l above basal at 60 minutes. CASA then 
fell rapidly and by 180 minutes had returned to basal values. 
There was no correlation between the RIA and CASA levels post-
prandially (G2 vs. CASA,r = 0.1056, 2604/7 vs. CASA,r = 0.0709) 
(Fig. 12.5). 
The RIA values measured by the two antisera however, showed 
significant correlation (2604 vs. G2; y = 1.2Jx · + 35-5; r = 
0.8500, p < 0.001). 
All samples of the serum from the post-prandial period diluted 
out parallel to the standard gastrin dose response curve. 
12:5:J Hypergastrinaemic Patients 
The CASA levels in the serum of the hypergastrinaemic patients are 
shown in Table 12:6, All diluted out in parallel with the standard 
G17-I gastrin curves. The fiducial limits for each measurement 
are shown in the Table. These varied from 63% to 164% (mean 
74.5o/o to 1J5o/o). The CASA of these patients is compared to the 
CASA of the 10 fasting normal subjects in Fig. 12:6. There is a 
significantly raised CASA in the hypergastrinaemic group. However, 
CASA did not correlate significantly with the immunoreactive 
gastrins in the same patients, measured with the G2 antiserum 
























































































































































































































































































































































































































~ .. ~ ....... -  Bioa~say 
TIME !minutes) 
120 
The mean immunoreactive gastrin measured by the 2 antisera 
(G2 and 2604/7) and the CASA measured by the cytochemical bio-
assay in the fasting state and the incremental rise following 
180 
180 
the mixed meal. + The points indicated are the mean (- SEM) of 10 
normal people, except at 5 minutes, where only 7 of the people 
were tested. 
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Correlations between immunoreactive gastrins and CASA in fasting 
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Comparison between the serum CASA of normal fasting subjects and 
hypergastrinaemic subjects and the correlation between the immuno-
reactive gastrins and serum CASA in these subjects. 
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12:6 Discussion 
The cytochemical section bioassay has streamlined the original 
segment bioassay described by Loveridge, Bloom et al, (1974). 
This was a tedious procedure in which segments of gastric mucosa 
were pre-incubated in tissue culture medium for 5 hours prior to 
treatment with different concentrations of gastrin. In contrast 
the section assay has the advantage of using a single iegment of 
gastric mucosa for the entire assay, thus eliminating excessive 
variations between segments. In addition, starving the guinea 
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pigs for 24 hours prior to killing eliminates significant variation 
in basal carbonic anhydrase (CA) activity and the response to 
gastrin stimulation is very reproducible. Thus th e s lopes of the 
standard curves varied less than 10o/o between assays whereas the 
interassay variation of a sample assayed on 6 occasions was JO% 
which is acceptable for a bioassay. The major problem however 
with the cytochemical bioassay in serum is that one is unsure of 
its specificity. Although it is unlikely that acetylcholine affects 
the assay as circulating levels are probably too low, histamine 
which activates CA in extremely low concentrations (Chapter 8), 
may well be present in serum, in concentrations high enough to 
have an effect on the CA activation. The finding of parallelism 
of the sample dilutions with the standard gastrin dose response 
does not exclude this possibility, as the mean slope of the histamine 
dose cu r ve (Chapter 8) is not very dissimilar to the slope of 
the gastrin curves. In addition the us e of affinity chromatography 
for gastrin may not have been totally specific for the reasons 
outlined. 
In addition there is a possibility that the CA activity is 
affected by acid inhibitors present in serum. Indeed, Loveridge, 
' Holle et al, (1978) have shown that secretin competitively anta-
gonizes the action of gastrin in the assay. Other possible 
enterogastrones have not been studied. For these reasons it was 
decided that rather than measuring biologically active gastrins 
in serum, this assay was measuring the carbonic anhydrase 
stimulatory activity (CASA) of serum. 
The presence of the numerous substances in serum affecting acid 
secretion is almost certainly one of the reasons for the finding 
of a poor correlation between the immunoreactive gastrins 
released after a meal and acid aec retion (Rich~rdson, Walsch et 
al, 1976). Another possible reaso~ i~ that secretagogues stimulate 
acid secretion via luminal, paracrine and neurocrine routes 
(Soll and Grossman, 1978), whilst a third reas-:>:1 may be altered 
sensitivity of the parietal cell mass to gastrins, as occurs in 
duodenal ulcer patients (Lam, Isenberg et al, 1980). 
The findings in this study, of a lack of correlation between 
im~unoreactive gastrins and CASA levels in serum are therefore 
not surprising, although they are at variance with those of 
Loveridge, Bloom et al, 1974. 
Richardson, Walsch et al, (1977) reported that the acid response 
to modified sham feeding ~ith gastric distension was similar 
to that occurring in the first JO minutes after a meal, and 
was independent of a change in immunoreactive gastrins. The 
gastrin effect on acid secretion only beca~e evident after 
60 minutes. 
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These workers suggested that food may release inhibitors which 
counteract the acid secretory effect of gastrins. The findings 
of a slow rise in CASA after a meal which did not parallel 
the immediate response of immunoreactive gastrins would be in 
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accord with this suggestion. Although the presence of inhibitors 
was not suggested bi a loss in parallelism between the serial 
serum dilutions and the standard curve, this does not necessarily 
exclude the parallel dilution of an inhibitor, particularly as 
only two dilutions of serum were, in general, tested. 
The more rapid fall in CASA levels compared with the RIA may be 
explained by changes in circulating forms of gastrins due to 
differences in half-life times. Following a meal, the concentration 
of G17 decreases more rapidly than GJ4. This was demonstrated 
by Dockray and Taylor (1976), who showed that by 120 minutes after 
a meal, G17 levels in the circulation were low, when the pre-
dominant remaining immunoreactive peptide was GJ4. As G17 is 
the predominant gastrin secreted after a meal (Lamers, Harrison 
et al, 1979), the fall noted in CASA levels may reflect the dis-
appearance of G17 from the circulation. 
Feldman, Walsch et al, (1978) found that an intravenous infusion 
of exogenous G17, which produced a serum concentration of G17 
similar to that following an intragastric infusion of peptones, 
resulted in a similar acid response in both cases. Thus it 
appeared that G17 in serum could account for all the gastrin-
stimulated acid secretion. It is of interest that these workers 
reported that the mean rise in G17 after a meal was 13 pmol/1, 
remarkably similar to the mean rise in this study (15 pmol/1). 
A further possible cause for the rapid fall in CASA levels may 
be the presence of enterogastrones entering the circulation and 
causing inhibition of net secretory potency. 
In the hypergastrinaemic patients, as in the normal subjects, 
there was no correlation between the CASA levels and the immuno-
reactive gastrin concentrations. It was however notable that 
-
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these patients' sera in general had markedly increased CASA levels, 
suggesting that gastrins were the major contributing factor to 
the CASA in- these patients. 
It is possible that the cytochemical bioassay may prove to be a 
useful additional test in the diagnosis of Zollinger-Ellison syndrome 
in certain "border-line" patients. An interesting e xample 
would be that of patient A.U. She had the Zollinger-Ellison 
syndrome by acid criteria but the serum gastrin was only slightly 
raised in the routine radioimmunoassay (G2). However her CASA 
was markedly raised, and the use of a second antiserum with a 
wider cross-reactivity showed grossly increased serum gastrin 
levels. This patient appeared to be secreting mainly sulphated 
gastrins which have only 7% cross-reactio~ with the G2 anti-
serum (Appendix 1) (Napier, 1978). However, before the cyto-
chemical bioassay can be used as a diagnostic test, further work 
is required to establish the mechanism of acid hypersecretion 
in the face of normal serum gastrins. (Bugat, Walsch et al, 1976). 
The cytochemical bioassay offers interesting prospects for 
these studies and may provide a tool for a better understanding 
of the functioning of parietal cells. 
CHAPTER 1J 
SUMMARY OF CONCLUSIONS 
The aim of this study was to use the technique of quantitative 
cytochemistry to study the effects of acid secretagogues on 
carbonic anhydrase (CA) activity in the parietal cells of guinea-
pig fundic mucosa. 
A specific cytochemical stain for CA activity was employ.ed and 
the density of the staining products was measured on a Vickers 
M85 scanning microdensitometer. The two major acid secretagogues, 
gastrin (2.J x 10- 15 to 2.5 x 10-
12
mol/l), histamine (5.8 x 10- 17 
to 1.0 x 10-
14 
mol/1) and the analogue of acetylcholine, carbamyl-
choline, (1.2 x 10-
12 
to 1.0 x 10-9 mol/1) caused linear increases 
in CA activity. The peak activation of CA induced by all three 
agents occurred after 90 seconds treatment of the sections and 
then declined in all cases. 
Gastrin had the greatest efficacy in that the maximal CA activity 
reached foilowing stimulation was approximately 50% higher than 
with either histamine or carbamylcholine. However the most 
potent secretagogue by comparing the n
50 
of the dose response 
curves, was histamine, which was approximately 100 times more 
potent than gastrin and 40,000 times more potent than carbamyl-
choline. Gastrin stimulated CA activity was inhibited by 
acetazolamide (10-5M), by boiling the tissue, and by anoxia. 
-16) The addition of subthreshold doses of gastrin (2.5 x 10 M 
and histamine (1.0 x 1o- 17M) to the dose response curves of 
histamine and gastrin respectively caused a significant left-
shift of each of the curves. 
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Gastrin increased both the efficacy and potency of the histamine 
response whereas histamine increased the potency of the gastrin. 
This suggests that histamine and gastrin potentiate each other 
and is consistent with the work of Soll (1978a, b, 1980), who 
studied oxygen and (
14
c)-aminopyrine uptake in isolated canine 
parietal cells. 
The addition of a subthreshold dose of histamine to the carbamyl-
choline dose response curve also caused a shift to the left of 
the curve, which was not significant, whereas gastrin had no effect 
on the carbamylcholine response. Atropine (to-5M) inhibited 
the effect of carbamylcholine but had no effect on hi stamine or 
gastrin~stimulated CA activity. The histamine H
2
-receptor 
blocker cimetidine (1o-5M) caused marked inhibition of the 
histamine effect (76! 7.8%), and slight inhibition of the gastrin 
effect (23! 4%) but no inhibition of carbamylcholine-stimulated 
CA activity. This suggests that gastrin and histamine act via 
pathways independent of the cholinergic pathways. The small 
inhibition of the gastrin effect by cimetidine may be due to 
inhibition of the effect of endogenous tissue histamine, necessary 
for the full gastrin effect. The lack of potentiation between 
histamine and carbamylcholine in this system cannot b e explained 
but there may be species variations. 
Lanthanum chloride (10- 6M) which acts by blocking calcium channels 
in membrane,inhibited carbamylcholine-stimulated activity by 
77! 8%, gastrin-stimulated activity by 45! 10% and histamine by 
This differential effect suggests that the secretagogues 
act at individual sites of action, possibly by separate mechanisms. 
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However, the potentiation of the gastrin and histamine effects 
suggests that these receptor sites may be inter-dependent in 
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that they require both sites to be filled to achieve maximal effects. 
The technique was further used to compare the potency of the 
gastrins at a cellular level. It appeared that the carboxy-
terminal decapeptide was necessary for full biological potency 
to be present. GJ4 had a similar potency to G17 but the slopes 
of the dose response curves were not similar, suggesting possible 
differences in modes of action. The amino-terminal fragment of 
G17 lacked all biological activity. 
Lastly, the method was used as driginally described for the cyto-
chemical bioassay of gastrin (Loveridge, Bloom et al, 1974). The 
reservations that this assay is actually specific for gastrin have 
been stated. Nevertheless, removal of gastrin from serum by 
affinity chromatography and charcoal adsorption removed all CA-
stimulating activity (CASA) and suggests that the serum gastrin 
is an important component of serum CASA. 
CASA activity increased equivalent to 15 pmol/1 gastrin after a 
meal, which is similar to the rise in G17 documented by Feldman, 
Walsch et al, (1978),whilst the peak CASA activity which occurred 
at 60 minutes after the meal coincided with the time at which 
it has been calculated that gastrin has its greatest effect on 
acid secretion (Richardson, Walsh et al, 1977). However there 
was no correlation between the CASA and immunoreactivity in the 
serum of normal subjects, either fasting or post-prandial nor 
in hypergastrinaemic patients, although in the latter the CASA 
was higher than in the normal subjects. 
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This suggests that the serum CASA does not totally reflect the 
biological activity of circulating gastrins, and this may be due 
to the presence of other acid secretagogues in t~e circulation. 
Alternatively, the biological activity of the various gastrins may 
not be accurately reflected by measurements of immunoreactivity. 
In view of the finding that the CASA was higher in the hyper-
gastrinaemic patients, it should be measured in diseases of acid 
hypersecretion not due to raised gastrin secretion, wh ere it may 
provide a useful diagnostic test. 
This thesis raises many questions and the c onc~usions can thus be 
considered as preliminary. 
in the next chapter. 
Some of these questions are discussed 
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CHAPTER 14 
CRITIQUE AND FURTHER QUESTIONS 
This thesis describes preliminary experiments which have 
explored the effects of the acid secretagogues on gastric parietal 
cell carbonic anhydrase (CA) activity. Dose-dependent increases 
of CA activity in response to gastrin, carbamylcholine and 
histamine have been demonstrated. The independent sites of action 
of the secretagogues are suggested by the specific inhibition of 
the carbamylcholine effect by the anticholinergic agent atropine 
and of the histamine effect by th e histam~ne H
2
-receptor blocker. 
The effect of gastrin, in contrast, is only slightly inhibited 
by cimetidine which may be due to inhibition of the effect of endo-
genous tissue histamine, as gastrin and histamine hav e been shown 
to potentiate each other. Cartramylcholine however, appears to 
act via a relatively independent cholinergic mechanism. Lastly, 
gastrin 
appears 
and7mylcholine but ' not histamine activation of CA 
to depend upon calcium flux, again suggesting separate 
sites of action. 
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Thus this work in some respects confirms Soll's hypothesis (1978a, b, 
1980), namely, that these agents have separate but interdependent 
receptors on the parietal cells. However this work differs from 
the findings of Soll in several respects. Firstly the gastrin 
effect at low concentrations d~d not depend upon the presence 
of a phosphodiesterase inhibitor or histamine. Secondly, Soll 
showed potentiation between histamine and carbamylcholine and 
although the data in this work tend to support this, the differences 
were not statistically significant. 
Whilst these differences may relate to species differences, 
they open up further questions along which lines this work should 
proceed. The most important of these is to determine the 
physiological relevance of CA activation in these studies and 
whether it truly relates to physiological acid secretion. There 
is great difficulty in explaining the effects of these secreta-
gogues at concentrations lower than that which normally elicits 
acid secretion in vivo. Thus the rise in gastrin levels after a 
meal causing submaximal acid secretion is in the range of 10 x 
10-
12
M. This concentration however, causes maximal CA activation 
in vitro. Furthermore, histamine requires even higher concentra-
tions to cause an effect in vivo but in vitro, activates CA at 
lower concentrations than gastrin. 
In addition, endogenous histamine occurs in gastric mucosa in 
microgram/gram wet wt. quantities and although the histamine con-
centration in the extracellular space is not known~ it has been 
estimated that it may be present in the nanomolar range. Thus 
the dose effect noted here at lower concentrations of histamine, 
is difficult to explain. It is possible that the above estimate 
of histamine levels is not correct because of the rapid tissue 
degradation of this substance, whilst the reason for the effect 
being seen at low concentrations in vitro may be that this 
preparation provides direct access to the parietal cells, which 
may reduce degradation. Furthermore the concentrations of gastrin 
at tissue level are not known and these may be below the 
circulating blood levels. Alternatively, perhaps in this in vitro 
preparation there is an absence of inhibitory substances which 
may tend to desensitise the effects in vivo. 
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However, information on these subjects is scant, and further 
work is required. A suggested explanation for the in vitro effects 
at low concentrations of secretagogues is that water may be 
absorbed into cells as a result of loss of cell membrane integrity, 
leaving the actual concentrations much higher than this level. 
Whilst this is unlikely, monitoring the concentrations of an 
extra-cellular marker such as inulin or mannitol may offer further 
insight into this problem. 
The transient nature of the secretagogue effects also needs to be 
explained. An. auto-feedback mechanism has been postulated . but this 
is speculative. The answers to both these two major quest ions may 
relate to the preparation per se. The question wh eth e r this 
preparation is viable, whether the cells are intact, and how 
long the tissue may be kept while remaining apparently functional, 
remain unanswered. It is even possible that the transience of the 
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response represents a "last gasp" effect of dying tissue. Alternatively 
intracellular negative feedback mechanisms may be operative and 
further work should be done to explore the nature of both the "on" 
and "off" mech a nisms of CA activation. 
One might argue that parietal cells which are snap-frozen and then 
sectioned, are disrupted and not truly viable. Some evidence that 
this is not the case has been presented, notably the lack of a 
response during anoxia, and the effects of lanthanum on the 
different acid secretagogue actions. Furthermore, the work of 
Chayen and colleagues (Chayen, Bitensky and Butcher, 1973), lends 
support to the contention that this particular method of freezing 
maintains relative cellular integrity. 
r 
One must nevertheless ask the question whether these cells can 
be regarded as functionally viable or whether an isolated 
cellular event is being monitored in non-intact cells? Related 
to this argument is the fact that adenylyl-cyclase may 
stimulate cyclic-AMP production in ' non-intact cells. Thus an 
altered specificity may occur in broken cell preparations and 
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may not have predictive value regarding the effects seen in intact 
cells. Thus until one is able to be sure that the cells are intact, 
one cannot make the assumption that this ~eflects stimulation of 
parietal cell acid secretory mechanisms. 
Possible methods of answering these problems include the measure-
ment of intracellular electrolyte concentrations a nd both trans-
epithelial and intracellular electrical potentials, as an index 
of membrane integrity and thus the viability of th e cells. However 
the best manner of showing the inter-relationshi~ b e twe en physio-
logical acid secretion and CA activation in this syst e m may be 
to devise a parallel system where other indices of acid secretion 
such as oxygen uptake could be simultaneously monitored. 
Thus this work is still inconclusive and opens up many questions 
in which direction further research should procee d. These include: 
1) A clea r demonstration of the viability or non-vi a bility 
of these sections. If the latter is found, then an 
explanation as to the clearly specific acid secretagogue 
responses is required. This will have great relevan~ e in 
the unde r standing of receptor interactions and mechanism of 
action of these agents. 
2) Further experiments to determine the relationship 
between CA activation in this system and acid 
secretion by the parietal cell. 
J) Further work to explain the transience of the secret-
agogue effect. If this is indeed an auto-feedback 
effect it is clearly of great physiological interest 
relating to the function and control of CA activity 
in parietal cells. 
4) Further experiments to determine in full the nature 
of the CASA of serum. Although the experiments 
described here tend to suggest that gastrin is the 
predominant factor contributing towards CASA, measure-
ments of histamine and acetylcholine in serum are 
required to ensure that these factors had not under-
gone degradation during the collection of the samples 
and subsequent tests. 
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5) Lastly, if the above questions are answered, there are 
several directions in which one could expand this study. 
The effects of acid inhibitors, including the pros.ta-
glandins and gut peptides on the parietal cells, and 
in addition the effects of calcium, c-AMP and other 
intracellular messengers may be studied. 
Furthermore, the use of this technique, as in this thesis, to 
study secretagogue potencies and the CASA of serum should be 
further expanded, with special reference to diseases of gastric 
acid secretion, such as duodenal ulceration, especially the group 
of acid hyper-secretors with normal serum gastrin . concentrations. 
This technique may thus help identify the presence of acid secret-
agogues other than those enumerated here and so thus lead to 
a greater understanding of the pathophysiology of these diseases, 
enabling us to rationalize our approach to prevention and treat-
ment of this world-wide problem. 
APPENDIX I 
A: RADIOIMMUNOASSAY OF GASTRIN 
Characteristics of Standards, Radiolabel and Aptiserum 
Immunoreactive gastrin was measured by modification of the method 
described by Yalow and Berson (1970). The standard used was 
synthetic human nonsulphated heptadecapeptide gas trin (SHG-17-I) 
which was freshly prepared for each assay and dissolved in 0.02M 
sodium barbital buffer pH 8.4, in concentrations ranging from 
J-400 pmol/1. 
125 Radio-labelled ( I) -G-17-I was purchased from 
CEA Sorin, France, and had a specific activity of 1000-1)00 µci/µg 
as determined by comparison of displacement of antibody-bound 
label by serial dilutions of the radiolabelled and cold gastrin. 
Two separate antisera were used: 
(a) Antiserum 2604/7 was a gift from Dr. J. Rehfeld of the 
Institute of Medical Biochemistry, Aarhus. It was 
raised by the immunization of a rabbit with human 
gastrin-I (2-17) conjugated to bovine serum albumin 
(Rehfeld, Stadil and Rubin, 1972) and was used in the 
assay in a final dilution of :1:100,000. 
(b) Antiserum G2 was similarly raised in our laboratory 
(Napier, 1978), and used in the assay in a final 
dilution of 1:500,000. The characteristics of the 
two antisera are compared in the Table A. Bombesin 
was received by courtesy of Dr. Erspamer, Farmitalia, 
Milan, and VIP by courtesy of Dr. Said, Dallas, Texas. 
The standard curves using antisera G2 and 2604/7 are shown in Fig.A 
The data was fitted to a logit/log plot of B/B
0
versus hormone ~ 
concentration and concentrations of gastrin obtained on a Hewlett 
Packard computer by lin ear regression analysis and substitution 
in the equation for a straight line. 
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Assay Procedure 
The assay procedure was similar for both antisera. To each tube 
was added 700µ1 sodium barbital buffer pH 8.4, 100µ1 of sample 
or standard, 100 µ1 antiserum and 100µ1 of the radio-labelled 
hormone (approximately 5000 c.p.m.). The tubes were allowed to 
. 0 
incubate for 24 hours at 4 C and free antigen was separated 
from antibody-bound antigen by precipitation with 500µ1 of 4% 
charcoal treated with dextran (o.4%) and centrifugation. The tubes 
were counted £or 10 minutes or 10 000 counts. The non-specific 
binding of label to charcoal was subtracted from each value. The 
initial binding, the inter-assay coefficient of variation and 
the recovery of known amounts of NHG-I added to serum is shown 
in Table A. 
B. PRODUCTION OF GASTRIN-FREE SERul-1 
(a) Charcoal-treatment of Serum 
Activated charcoal added to serum adsorbs peptides and s~all 
molecules. In a 2% suspension the charcoal will strip the majority 
of gastrin-17 and J4 from serum but not Big-big gastrin (BBG) 
(Yalow and Wu, 1973). 20mg. of activate~ charcoal (Norit A) was 
added to 1 ml. of normal fasting serum. This was stirred for 1 
hour at room temperature and left overnight to stand at 4
6c. The 
suspension was then filtered and centrifuged. Gastrin immuno-
reactivity measured by the G2 antiserum was reduced from 17.5 
pmol/1 to 12.5 pmol/1 after treatment. 
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(b) Affinity Cromatography 
Affinity chromatography is a type of adsorption chromatography 
in which the bed material has affinity for the substance to be 
isolated. The adsorptive properties of the bed material are 
obtained by covalently coupli~g an appropriate ligand binding 
substance to an insoluble matrix. The coupled ligand is able to 
bind the required substance from the samples which can then be 
eluted by altering the eluting fluid after the non-bound 
substances have passed through the column. Alternatively, if 
sufficient passes of the sample are made through the column one 
may obtain a sample free of the bound substance. 
In order to remove gastrin-like immunoreactivity from serum, G9 
antiserum, which was prepared by inoculation of a rabbit with 
SHG-17-I coupled to whelk haemacyanin (Napier, 1978), was coupled 
to CN-Br activated Sepharose 48 (Pharmacia Fine Chemicals, 
Uppsala, Sweden), using carbadimide as the coupling agent by the 
method of Cuatrecasas (1970). This antiserum recognized both 
synthetic and natural human gastrins G17 and GJ4. 
A column of antibody-sepharose complex was poured into a 2ml 
plastic syringe with a glass wool base. One ml of fasting serum 
diluted 1:8 in 0.02M barbital buffer pH 8.4 was passed through the 
column in a continuous circulation over a period of 8 hours at 
22°c by peristatic pump (8 passes). The diluted serum was then 
assayed by radio-immunoassay using the G2 antiserum and was 



































































































































































































































































































































































































































































































































































































































30 ... ... Antiserum G2 
20 • • Antiserum 2604/7 
10 
0 
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Gas tr in - 17 - (moles/liter) 
FIG. A Radioimmunoassay standard curves of g astrin using 




STATISTICAL MEXHODS . (Snedecor and Cochran, 1967) 
X 
A MEAN E -= X n 
Where X = the observations 
= the sum of 
n = the number of observations 
2 
E( X-X) 
B STANDARD DEVIATION (SD) SD = 
n 




D COEFFICIENT OF VARIATION (CV) - X 100 = X 
E EQUATION OF A STRAIGHT LINE y = a + b X 
or 





F CORRELATION COEFFICIENT r = Y} 
Z:(y -)2 - y 
n Z: XY - L X Z:-Y 
G SLOPE b ( or m) = 
Ex} 2 n L x2 - ( 
a (or c) !:Y -
b r.x 
H INTERCEPT = 
n 
{i; STD DEVIATION SLOPE Sb j E(! - y I = - 2 
A 2 
I'. (Y - y) 
J STD ERROR OF ESTIMATE Sxy = 
n - 2 
K INDEX OF PRECISION = Sxy/b 
L CONFIDENCE LIMITS 
The confidence intervals about a calibration line represent 
parabolas above and below the lines with the uncertainties 
being smallest near the mid-point of the data used to establish 
the line and expanding near the extremes. 
Y = a + b x :: S xy + j : + 
M STUDENT'S t-TEST 
t = x1 - x2 
j ( SD 1) 2 + ( SD 2 ) 2 
n1 n2 
- 2 
(X - X) 
x2- n x2 ) 
N A - I & M were calculated on the Hewlett Packard statistics pac 
(9162 - 0050 Digital Cassette) on a Desktop Calculator Model 
98JOA. 
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J, Kand L were calculated by a programme designed specifically 
for this thesis (see programme 1, page 204)~ 
Comparison of regression lines for variance and parallelism 
was done by analysis of covariance (Snedecor and Cochran, 1967). 
(see programme 2, page 205). 
In the determination of p, significance was accepted at the 
5% level ( p < 0.05). 
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